1

1

Archives

(Glick Collection)

September 10, 2015

Revised, June 21, 2015,

Curriculum Vitae,

Ira David Glick, MD

Professor Emeritus of Psychiatry, Dept. of Psychiatry & Behavioral Sciences

Stanford University School of Medicine;

401 Quarry Road

Stanford, CA 94305-5546

(650) 799 1583 (cell)

iraglick@stanford.edu

Visiting Scholar, School of Medicine, University of California, San Diego, La Jolla, Ca

Visiting Fellow in Psychiatry, Weill Cornell Medical College, New York, N Y

Date of Birth: October 15, 1935 Place of Birth: Brooklyn, New York

Education:

1957 B.S., Dickinson College, Carlisle, Pennsylvania

1961 M.D., New York Medical College, New York, New York

Postgraduate Education:

1961-1962 Rotating Internship, Beth Israel Hospital, New York, NY

1962-1966 Psychiatry Residency

1962-63 - First Year Resident, Hillside Hospital, Glen Oaks, New York

1963-64 - Second Year Resident, Mt. Zion Hospital, San Francisco, California

1964-65 - Chief Resident, Hillside Hospital

1965-1966 Candidate, New York Psychoanalytic Institute, New York, NY

Licensure & Certification:

1962-1993 New York State Medical License

1963 Diplomate of the National Board of Medical Examiners

1963- California State Medical License (G 9084)

1968 Diplomate of the American Board of Psychiatry and Neurology

1980 Mental Health Administrator, Commission on Certification in Administrative Psychiatry of

the American Psychiatric Association

1988-1990 Maryland Medical License

Academic Appointments:

2

2

1965-1968 Instructor & Assistant Attending Psychiatrist, New York State Psychiatric Institute,

College of Physicians and Surgeons, Columbia University

1966-1968 Assistant Clinical Professor of Psychiatry, Medical College of Georgia

1968-1978 School of Medicine, University of California, San Francisco (UCSF):

1968-72 Assistant Clinical Professor of Psychiatry and of Obstetrics & Gynecology

1971-73 Career Teacher in Psychiatry of the National Institute of Mental Health at

Langley Porter Neuropsychiatric Institute

1972-76 Associate Clinical Professor

1976-78 Professor of Psychiatry in Residence, School of Medicine

1978-1993 Professor of Psychiatry, Cornell University Medical College, New York, NY

1993- Professor of Psychiatry & Behavioral Sciences, Stanford University School of Medicine

• 2010 Emeritus Professor

Positions:

1965-1966 Staff Psychiatrist and Research Associate, Hillside Hospital, Glen Oaks, New York

1966-1968 Service Record: Captain, Army of the United States, Chief, Psychiatry Service,

U.S. Army Hospital Specialized Treatment Center, Fort Gordon, Georgia

1968-1978 Langley Porter Neuropsychiatric Institute and Dept. of Psychiatry, School of Medicine,

University of California, San Francisco

1968-78 Chief, Clinical Research Ward (renamed the Inpatient Treatment & Research

Service, 5/1/75)

1975-78 Director, Medical Student Education

1978-1993 Associate Medical Director, Payne Whitney Clinic, Dept. of Psychiatry, The New York Hospital-

Cornell Medical Center

1978-88 - Director, Inpatient Services

1978-93 - Director of the Family Therapy Program

1990-93 - Director, Outpatient Dept.

1988-1990 Senior Science Advisor to the Director, National Institute of Mental Health, Rockville, MD, 80%

1993- Stanford University School of Medicine & Stanford University Hospital

1993 - 2000 - Director of Inpatient & Partial Hospitalization Services,

1995 - 96 - Acting Deputy Chief of Staff and Chief of Psychiatry,

Palo Alto Veterans Administration Hospital

1993 – 2012 - Director, Schizophrenia Research Clinic

2010- Medical Director, Pacific Research Partners, Oakland, CA

2000- The American Society of Clinical Psychopharmacology

Editor, Model Psychopharmacology Curriculums for Teachers of Psychopharmacology to

Residents, Medical Students and Primary Care Physicians,

Private Practice:

New York City: 1965-66 and 1978-93

San Francisco:

o 1968-78 and 1993-present

3

3

Other Training:

1965-1966 Dept. of Research, Hillside Hospital: Seminar on Research Methods in Psychiatry, D. Klein, MD

1968-1969 J. Starkweather, PhD, Dept. of Information Systems, UCSF: An Introduction to Computer

Programming PL-1

1968-1969 Dept. of Psychiatry, UCSF: Seminar on Supervision, R. Wallerstein, MD

1968-1969 Dept. of Psychiatry, UCSF: Seminars on Models in Psychiatry, J. Ruesch, MD

1969-1970 Dept. of Psychology, Langley Porter Neuropsychiatric Institute: Course on Advanced

Statistics, W. Hargreaves, PhD

1971-1972 Dept. of Psychology, Langley Porter Neuropsychiatric Institute: Advanced Statistics

226- A & B, R. Elashoff, PhD and W. Hargreaves, PhD

1971-1972 UCSF: Health Sciences Education Seminar, E. Rosinski, PhD

1972 Dept. of Anatomy, UCSF: Course on Cell Structure & Function, R. Long, PhD

1972 Dept. of Physiology, UCSF: Course, Endocrinology 101, C. Kragt, PhD

1972 Dept. of Business Administration, Philosophy of Management University of California,

Berkeley Science, C. Churchman, PhD

1973 Cardiovascular Research Institute, UCSF: Group Practice in the Art of Teaching, N. Staub, MD

1978-1979 Dept. of Psychiatry, Albert Einstein College of Medicine: Administrative Psychiatry &

Mental Health Planning, S. R. Kaplan, MD

Honors and Awards:

1953-1954 Skull & Key Award: Dickinson College. One award, given yearly to the college's “most outstanding

freshman”

1959 National Foundation Medical Student Fellowship, Dept. of Physical Medicine & Rehabilitation,

New York Medical College (Summer)

1960 National Institute of Mental Health Research Training Grant , Dept. of Psychiatry, New York

Medical College (Summer)

1961 Stephen P. Jewett Award : Dept. of Psychiatry, New York Medical College. One award given

each year for proficiency in psychiatry to a fourth year medical student

1968 Army Commendation Medal : U.S. Army Hospital, Ft. Gordon, Georgia

1971-1973 Career Teacher in Psychiatry: National Institute of Mental Health, MH-12450

1974-1975 Dept. of Psychiatry Nominee for the Kaiser Award for Excellence in Teaching, and

the UCSF Budget Committee Award for Special Recognition of Distinction in Teaching

1979 American Journal of Nursing, 1979, Books of the Year Award, presented for "Psychiatric

Hospital Treatment for the 1980's"

4

4

1974-1978 Consultant, Psychiatric Education Branch of the National Institute of Mental Health

1979-1980 Ad Hoc Reviewer for the Psychosocial & Biobehavioral Treatments Subcommittee of the

Treatment Development and Assessment Research Review Committee, NIMH

1982 Member, Special Review Committee on Depression, ADAMHA, NIMH (July)

1987 Fulbright Research Scholar, Japan, (January through July)

1987 Research Fellowship, the Japanese National Institute of Mental Health, Itchikawa, Japan,

(January through July)

1987 The American Psychiatric Association and Psychiatric Institute of America (PIA) Award for

Hospital Psychiatric Research, awarded annually for research in the field of hospital psychiatric

treatment.

1986- The Best Doctors in America

1990 The Seymour D. Vestermark Award, awarded annually "to recognize leadership & creativity in

psychiatric education, "by the American Psychiatric Association, (given to the ACNP for a Model

Curriculum in Psychopharmacology developed by a subcommittee which I co-chaired with David

Janowsky, MD)

1990 Director's Award, National Institute of Mental Health

1991 The Association for Academic Psychiatry Psychiatric Education Award, Honorable Mention,

awarded biannually for Innovative Educational Materials and Techniques, for the Model

Curriculum in Psychopharmacology

1991 One of three recipients of Alumni Achievement Awards from New York Medical College

1991 Runner-up for The American Academy of Clinical Psychiatrists Clinical Research Award

1991-1994 MacArthur Foundation Research Network on Depression

1993 The Van Ameringen Award in Psychiatric Rehabilitation, awarded annually by American Psychiatric

Association, in recognition of outstanding and sustained contributions to field of psychiatric

rehabilitation in areas of research, service and education (in 1992, I was given “Honorable Mention”

for this same award)

1994 The Alexander Gralnick Award,for Research in Schizophrenia, given annually by the American

Psychiatric Foundation to a researcher “whose work covers the psychosocial aspects of

schizophrenia with an emphasis on the early stages of the disorder.”

1996 Association for Academic Psychiatry Annual 1997 Education Award for “outstanding

contributions as an educator, both in curriculum development and in presentation”

2000 Annual Outstanding Achievement Award of the Northern California Psychiatric Society (NCPS) of

the APA, “recognizes a member of NCPS who has made significant and exceptional contributions

to the field of psychiatry.”

2001 Distinguished Contribution to Family Systems Research Award. This annual AFTA award

recognizes an individual for outstanding research on subjects central to the field of family therapy.

5

5

2002 Rockefeller Foundation Award for Residence at Bellagio, Italy, Summer 2002.

2003 Metzger-Conway Fellow, Clarke Center, Dickinson College, Carlisle, PA

2003 Fulbright Lecturing Award, India

2004 Excellence in Teaching Award, Stanford University School of Medicine, Stanford, CA. In

recognition of “contributions to the educational mission of the school.”

2004 Nominee for Franklin G. Ebaugh, Jr. Award for excellence in teaching, Stanford University School

of Medicine

2005 First Annual Irma Bland Award for Excellence in Teaching Residents, given annually by the

American Psychiatric Association to Departments of Psychiatry for” outstanding and sustaining

contributions made as a faculty.”

2005 Paul Hoch Distinguished Service Award for Contributions to the College, from the American

College of Neuropsychopharmacology

2006 Dickinson College Distinguished Alumni Award for Professional Achievement. This yearly award

names alumni “ who have demonstrated outstanding accomplishment, as well as strength of

character, in their professional and civic lives.”

2006 CINP 2006 Lundbeck Neuroscience Foundation Prize for Education in Psychiatry and Neurology,

one award given every 2 years for “education in psychiatry and neuroscience to an individual (or

group) who has attained particularly valuable achievements in the field of postgraduate education

in psychiatry and neuroscience.”

2008 The American College of Psychiatrists’ (ACP) Distinguished Service in Psychiatry Award, one

award given each year to “recognize distinguished achievements and leadership in the field of

psychiatry. “

2008 The Association for Academic Psychiatry, Distinguished Life Fellow, given each year for “mastery

in a career dedicated to educational endeavors, demonstrated generativity by unselfishly guiding

the next generation of academic psychiatrists, and engaged in passing on the traditions of the

past to the next generation of academic psychiatrists. “

2010 Exemplatory Psychiatrist Award, from the National Alliance of Mental Illness (NAMI), the largest

family mental health advocacy group in the country, for ” his work in helping patients and families

with serious mental illnesses.”

2013 2014 American Psychiatric Association Kun-Po Soo Award, “recognizing an individual who has

made significant contributions toward understanding the impact and import of Asian cultural

heritage in areas relevant to psychiatry,”

Visiting Professorships (VP) & Endowed Lectures:

1972 VP: Dept. of Psychiatry, School of Medicine, University of San Marcos, Lima, Peru, (August)

1) Teaching of Psychiatry to Medical Students

2) Family Therapy Today

1978-1988 Distinguished Lecturer, Lederle Pharmaceutical Co

6

6

1979 VP: Dept. of Psychiatry, College of Medicine, University of Arizona, Health Science Center,

Tucson, Arizona

1980 Gary N. Spero Community Mental Health Memorial Lecture Series, "The Family Model in

Inpatient and Day Hospital Settings," Maimonides Medical Center, Brooklyn

1980 VP: Dept. of Psychiatry, University of Connecticut Health Center, Farmington, Connecticut

1981 VP: Maudsley Hospital, Tavistock Clinic and Hospital for Sick Children, London

1) "The Family Model in an Inpatient Setting", Seminar on Hospital Psychiatry,

Mental Health Workers, Great Britain

2) "Family Therapy and Hospitalization", Tavistock Clinic

3) "Family Research", Marlborough Hospital

4) "Family Research", Grand Rounds, Hospital for Sick Children

5) "Indications and Contraindications for Family Therapy", The Family Institute of London

1982 Keynote Address, "Guidelines for Family Therapy," as part of a continuing education course

entitled "Clinical Techniques for the Practice of Family Therapy," sponsored by the Dept. of

Psychiatry, Long Island Jewish- Hillside Medical Center

1982-1989 Visiting Faculty Program, Mead Johnson Pharmaceutical Co.

1983 VP: Dept. of Psychiatry, University of California, San Diego

1983 VP: Dept. of Psychiatry, College of Medicine, University of Arizona Health Sciences Center,

Tucson

1984 Schweppes Visiting Professor, The Menninger Clinic, Topeka

1985 VP: Dept. of Psychiatry, University of Wisconsin Medical School, Madison, "The Shrinking of

Hospital Psychiatry"

1985 VP, Dept. of Psychiatry, Medical University of South Carolina, Charleston

1) Grand Rounds, "Inpatient Family Intervention - A Controlled Study"

2) Inge Taylor Memorial Lecture, "Why Don't Patients Receive Appropriate Psychiatric

Treatment?"

3) All Day Seminar with Psychiatry Residents, "Theory & Practice of Integrative Psychiatry"

1985 VP: Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine,

Dept. of Psychiatry, "The Family Model: Does It Have Anything to Offer for the Treatment of

Affective Disorders?"

1985 VP: Fairfield Hills Hospital, Newtown, Connecticut, "Treating the Hospitalized Patient and

Their Family"

1986 VP: Dept. of Psychiatry, School of Medicine, University of Verona, Italy, Jan-Jun

1990 Visiting Lecturer Series, "Effectiveness in Psychiatric Care," New Jersey College of Medicine

and Dentistry, Newark

1990 Invited Speaker, "What a Psychiatric Hospital Can and Cannot Do: A Review of Efficacy

Studies." at a conference, "The Role of the Mental Hospital in the 21st Century," sponsored

by the London Psychiatric Hospital, Ontario, Canada

7

7

1990 Invited Lecture, "New Wine in New Bottles: The Changing Role of Psychiatric Hospitals for

Patients and Their Families," at The Sheppard Pratt National Symposium on Schizophrenia,

Baltimore

1991 Academic Lecture: "New Models for the Treatment of the Chronically Mentally Ill," Annual

Meeting of the Ontario Psychiatric Association, Toronto (February)

1991 Invited Lecture: "A Survival Guide for the Family of the Borderline Patient (and Vice Versa),"

New Approaches to the "Borderline Syndrome," Sixth Tokyo Institute of Psychiatry

International Symposium, Tokyo, Japan (November)

1993 VP & Invited Lecture: University Institutions of Psychiatry, Geneva, School of Medicine,

University of Geneva, Switzerland and Invited Lecture, "Effectiveness in Psychiatric Care: A

Followup Study of the Treatment of Hospitalized Patients with Major Affective Disorder seen

in Europe, Asia and the U.S. United States" (April)

1993 VP: Institute of Clinical Psychiatry, School of Medicine, University of Pisa, Pisa, Italy, with

Invited Lecture, "Effectiveness in Psychiatric Care: A Followup Study of the Treatment of

Hospitalized Patients with Major Affective Disorder in Europe, Asia and the United States"

1993 Invited Lecture, "Effectiveness in Psychiatric Care: A Followup Study of the Treatment of

Hospitalized Patients with Major Affective Disorder in Europe, Asia and the United States,"

Dept. of Psychiatry, Second School of Medicine, Naples, Italy (April)

1993 Invited Lecture, "Effectiveness in Psychiatric Care: A Followup Study of the Treatment of

Hospitalized Patients with Major Affective Disorder in Europe, Asia and the United States,"

Institute of Clinical Psychiatry and the Dept. of Psychiatry, School of Medicine, Verona, Italy.

1994 Academic Lecture: "Combining Medications with Psychosocial and Rehabilitation Strategies

for the 1990's," 2nd Annual Psychopharmacology Clinical Day, Department of Psychiatry,

University of Toronto, Toronto (October).

1995 Distinguished Lecturer, Professors of Psychiatry Series: New Strategies of Treatment for Axis I

Disorders, 1995.

1995 VP, Department of Psychiatry, School of Medicine and Surgery, University of Bari, Italy, June.

Keynote Speaker, Strategies of Intervention in Family Psychotherapy, First National

Congress, Italian Society for Research and Interventions on the Family, Subsection of the

Italian Psychiatric Society .

1996 Keynote Address, Combination Therapy for the Treatment of Psychosis, Third Annual STEP

Symposium, Improving the Prognosis of Psychotic Disorders (Schizophrenia Treatment &

Evaluation Program), University of North Carolina at Chapel Hill, June, 1996.

1996 Keynote Address, Combination Therapy for the Treatment of Axis I Disorders, 1996 Taipei

Mental Health Conference, Taipei, Taiwan, December 1996.

1997 VP, Department of Psychiatry, University of Iowa Hospital and Clinics, Iowa City, March 1997.

1997 Award Lecture, Through the Golden Chalkboard: Reflections on the Teaching-Learning Process

in Psychiatry, 1997 Annual Meeting of the Association of Academic Psychiatry, March, 1997.

1998 VP, Department of Psychiatry & Internal Medicine, St. Francis Medical Center, Pittsburgh, PA,

1998.

8

8

1998 Principal Speaker, “Lone Star : Society, The Family and Individual Identity,” as part of the film

series of the New Orleans Museum of Art and Department of Psychiatry LSU, entitled: Lights,

Camera - Analysis, “ New Orleans, October, 1998.

1998 Keynote Speaker, “New Treatments for Schizophrenia and Other Psychoses,” at the National

Satellite Symposium for the Argentine Psychiatric Society, “Time for Change in the Treatment of

Psychosis, “ Buenos Aires, Argentina, November, 1998.

1998 Principal Speaker, at the National Conference organized by the Uruguayan Ministry of Health,

Uruguayan Society of Psychiatry and the Psychiatric Department of the School of Medicine in

the National University, Montevideo, Uruguay, November 1998:

• “New Atypical Antipsychotics and Their Indications”

• “Combining Medication and Psychotherapy for Axis I Disorders”

1999 Visiting Professor, University Hospital Utrecht, The Netherlands, Summer 1999.

1999 Plenary lectures at the Schizophrenia Symposium, Eastern Idaho Regional Medical Center, Idaho

Falls, ID, June, 1999:

• “New Strategies for the Treatment of Axis I Disorders”

• “New Treatments for Schizophrenia”

1999 Plenary Lecture, “New Diagnostic Methods and Treatments for Schizophrenia: Turning the

Treatment Corner” at the Annual Meeting of the Canadian Psychopharmacologic Association,

Halifax, June, 1999

2000 Guest Lecture, “The New Atypical Antipsychotics for New Indications,” Annual Meeting, Korean

Psychopharmacology Association, Korea, April, 2000.

2000 Visiting Professor, EPPIC Program, University of Melbourne, Melbourne, Australia, August, 2000.

2002 Invited Lecture, “Novel Antipsychotics: What We’ve Learned; What We Need to Know.” CME

course on Novel Antipsychotics, Case Western Reserve University School of Medicine,

Cleveland, September, 2002.

2004 Visiting Professor, Family Studies Unit, National Institute Mental Health and Health Series

(NIMHANS), Bangalore, India

• “Combining Medication and Psychotherapy”

• “The New Model of Inpatient Psychiatry”

2004 Inaugural Lecture, “Gary N. Spero Memorial Lectureship, “Schizophrenia and Psychosis: New

Data, New (Combined) Treatments & New Controversies.” Department of Psychiatry, Weill

Medical College of Cornell University, New York, March, 2004.

2004 Visiting Professor, School of Medicine, University of Iowa

• Combining Medication and Psychotherapy for Axis I Disorders

• Schizophrenia: New Data and New Controversies

2005 At the Indonesian Society for Biological Psychiatry, Psychopharmacology and Sleep Medicine,

Jakarta, Indonesia, February, 2005.

• Educational Symposia, “The Teaching of Psychopharmacology: Circa 2005”

• Opening Plenary Lecture: “Developing a Curriculum in Psychopharmacology”

9

9

2005 Lecture: “Developing a Curriculum in Psychopharmacology.” Teaching Psychopharmacology:

Substance, Methods, Science. Pre-Meeting: American Association of Directors of Psychiatric

Residency Training, Tucson, AZ, March, 2005

2005 Invited Lecture, “Collaboration With Big Pharma,” as part of the Stanford Summer Research

Institute, entitled Careers in Geriatric Psychopharmacology. Stanford, CA, July, 2005

2006 Invited Lecture. “Using a Psychopharmacology Curriculum to Improve Training.” Dept of

Psychiatry, Cape Town Medical School, Cape Town, South Africa, April, 2006

2006 Invited Lecture: “CATIE Trial Results.” At the Annual ECNP (European College of

Neuropsychopharmacology) Meeting, Paris, September 2006.

2007 Invited Lecture: “Clinical Antipsychotic Trials in Intervention Effectiveness.” Oregon Psychiatric

Association, Lake Oswego-Portland, OR, March 2007.

• Panel Discussion on CATIE trial, “ with W Hoffman, M Reaves, D Ruthven

2007 Invited Lecture: “Teaching of Psychopharmacology Worldwide,” consultant for the Lundbeck

Institute, Copenhagen, Denmark, March 2007.

2007 Invited Participant: “Joint Committee on Long-Term Management of Schizophrenia,” Houston,

April and October, 2007, Chaired by William Carpenter and John Newcomer.

2008 Visiting Professor and Invited Lectures: “The Teaching of Psychopharmacology: 2008,”

• Department of Psychiatry, Sackler School of Medicine, Tel Aviv University

and Sheba Medical Center, Tel Aviv, Israel

• Department of Psychiatry, Rappoport Faculty of Medicine Institute of Technology, Technion,

Haifa, Israel

2008-2011 Visiting Professor and Invited Lectures at the Institute of Clinical Psychiatry and Polyclinica

Hospital, University of Milan, Italy.

• 1) “Update on Treatment of Schizophrenia”

• 2) “Combining Medication with Psychotherapy for Axis I Disorders.”

2009 Invited Lecturer: “How We Should Teach Psychopharmacology,” ECNP School of

Neuropsychopharmacology, St Catherine’s College, Oxford, England, July, 2009

2009 Inviited Lecture: “Current Status and Overview of Marital and Family Psychotherapy, at the

Psychotherapy Institute, Dept of Psychiatry, School of Medicine, University of Verona, Italy,

October, 2009

2010 Visiting Professor and Invited Lecture at the Department of Psychiatry, Penn State College of

Medicine, Hershey, PA, January 2010

• “Long-term Treatment of Schizophrenia with Antipsychotics: Recent Research”

• “Combining Drugs and Psychotherapy for Axis I Disorders”

2010 Visiting Professor, sponsored by the Clark Center at Dickinson College, Carlisle, PA, Jan 2010

• “The New Neuroscience, Psychology and Psychiatry: History and Challenges for the Future

• “The Athlete as Role Model: Life after Sports”

2010 Visiting Professor, Update on the Treatment of Schizophrenia, School of Medicine, University

Psychiatric Center, Casablanca Morocco, April, 2010

2011 Visiting Professor and Invited Lecturer: 1) Combining Medications and Psychotherapy for

10

10

Axis I Disorders, and 2) Updates on Treatment of Schizophrenia, at the Department of

Psychiatry, School of Medicine, Penn State Hershey, November 2011.

2011 Plenary Lecture, Psychopharmacologic Treatments for Schizophrenia, at the Annual Meeting of

the Nevada Psychiatric Association, Las Vegas, February 2011

2012 Course Coordinator and Lecture, Update on Schizophrenia, at the Annual CME Course for the

Nevada Psychiatric Society, Las Vegas, February, 2012

Lecture, Long-term Management and Treatment of Chronic Schizophrenia

2013 Invited Plenary Lecture: Pulling Together the Data: Lifetime Treatment of Schizophrenia, Annual

Meeting, Alberta Psychiatric Society, Banff, Canada, March, 2013.

2013 Invited Grand Rounds: Mid-term and Long-term Treatment of Schizophrenia, Harvard Longwood-

Mass Mental Psychiatry Department, Boston, March, 2013.

2014 Invited Lecture: The New Neuroscience-and Psychology, Psychiatry and Medicine, The Clarke

Forum for Contemporary Issues, Dickinson College, Carlisle, Pa, Feb. 2014 and at Dept of

Neuroscience, Wesleyan University, Middletown, Conn, May, 2014.

2014 Award Lecture: The Ascent of Asian Psychiatry, delivered for the Kim-Po Soo Award at the Annual

Meeting of the American Psychiatric Association, New York, May, 2014.

2014 Visiting Scholar Series: Mid and Long-Term Treatment of Schizophrenia McLean Hospital,

Harvard Medical School, Boston, September, 2014.

2015 Distinguished Speaker Series: Combining Psychotherapy with Pharmacotherapy: Data, Benefits

and Guidelines for Integration, Semel Institute for Neuroscience and Human Behavior at UCLA,

Los Angeles, March, 2015

Funded Research Activities:

1965-66 G.D. Searle Research Grant for the study

Pseudopregnancy Treatment of Periodic Psychiatric Illness

1971-75 National Institute of Mental Health Grant for the project MH-20593

Short vs. Long Psychiatric Hospitalization: A Controlled Study $133,000

Supplement $ 25,484

1975-77 Lederle Research Grant for the study

Loxitane Treatment in Schizophrenia

1977-1978 Endo Research Grant for the study

Molidone Hydrochloride vs. Haloperiodol:

Double Blind Investigation of the Treatment of Acute Schizophrenia

1977-1982 National Institute of Mental Health Grant for

Medical Student Psychiatric Education, MH-10569 $395,280

1977-1978 Vice Chancellor's Advisory Committee on Instructional

11

11

Improvements Grant, UCSF, for project Effectiveness and

Efficiency in Small Group Teaching with Mary Malloy, MD $ 1,400

1982-1983 National Institute of Mental Health - Biomedical Research Support

Grant for the study Inpatient Family Intervention: A Controlled Study $ 15,000

1982-1983 National Institute of Mental Health Contract -to develop a Model

Psychopharmacology Curriculum for Psychiatric Residency Training

Programs 83K055987501D (with David Janowsky MD) under the

auspices of the American College of Neuropsychopharmacology $ 4,290

1984-1986 National Institute of Mental Health Grant for project

Inpatient Family Intervention: Evaluation of Practice, MH-34466 $180,000

1984-1993 National Institute of Mental Health, Cooperative Clinical Agreement Award

for the project, Treatment Strategies in Schizophrenia, MH-40007 $863,000

1987-89 Supplement $104,000

1989-92 Competitive Renewal $688,581

1992-93 Supplement $ 30,000

1987 Fulbright Research Award for the project,

Delivery and Compliance to Good Medical Treatment $ 20,000

1991 Janssen Research Grant for the study, Risperidone in the

Treatment of the Negative Symptoms of Schizophrenia

1992-1995 National Institute of Mental Health Grant, Marital Treatment

for Bipolar Disorder Patients, MH-45528-01A3,

Co-Principal Investigator with John Clarkin, PhD, P.I. $520,000

1992 (Cornell) Abbott Laboratories Research Grant for the study: Depakote in the

& Prevention of Mania

1993 (Stanford)

1992 Pfizer Research Grant for the study: CP-88 for the Treatment

of Schizophrenia and Schizoaffective Disorder

1992 (Cornell) Abbott Laboratories Research Grant for the study: The Safety

& and Efficacy of Sertindole in Schizophrenic Patients:

1993 (Stanford) A Double-Blind, Haldol-Referenced, Placebo-Controlled Study

1993 Pharmacologic Medication Discovery & Development Project (PMDDP) $10,000

Supported by SmithKline Beecham, Lilly & Abbott Laboratories

1993 Pfizer Research Grant for the study, Treatment of Adolescent Depression

with Sertraline

1993 Abbott Laboratories Research Grant for the study, Safety and Efficacy

of Depakote in the Prevention of Mania in Patients With Bipolar Disorder

1995 Eli Lilly unrestricted treatment grant to develop a Model Psychopharmacology

Curriculum for Residents (Committee Chair) under the auspices of

the American Society of Clinical Psychopharmacology

12

12

1995 Eli Lily Research Grant for the study, Olanzapine versus Risperidone

in the Treatment of Schizophrenia and other Psychotic Disorders

1995 Upjohn Research Grant for the study, Dose-response Study in the $50,000

Treatment of Negative Symptoms of Schizophrenia with Pramipexole

1995 Abbott Laboratories Research Grant for the study, A Comparative Cost

Effectiveness Study of Depakote and Usual Care versus Lithium and

Usual Care in the Treatment of Bipolar Disorder

1996 Zeneca Pharmaceuticals Research Grant for the study, A Multicenter,

Open, Randomized Comparison of Seroquel and Usual Care on Health

Outcomes in Subjects with Schizophrenia and Schizoaffective Disorder

1997 Hoechst Marion Roussel Research Grant for the study, A Multicenter,

Randomized, Double-Blind, Placebo and Active Controlled Study of

MDL 100,907 in Schizophrenic and Schizoaffective Patients

1997 Otsuka America Pharmaceutical, Inc. Research Grant for the study,

A Phase III Double-Blind Placebo-Controlled Study of Aripiprazole

in the Treatment of Psychosis, with Risperidone as Active Control

1998 Novartis Pharmaceuticals Corporation, A Prospective, Randomized, International,

Parallel-group Comparison of Clozaril/Leponex vs. Zyprexa in the Reduction of

Suicidality in Patients with Schizophrenia or Schizoaffective Disorder Who Are At

Risk for Suicide

1998 Zeneca Pharmaceuticals Research Grant for the investigator initiated $100,000

study, Quetiapine vs Haloperidol Decanoate for the Long-Term

Treatment of Schizophrenia and Schizoaffective Disorder

with Marder S.

1998 Lilly Research Labs, The Acute and Long-Term Efficacy of Olanzapine

in First-Episode Psychotic Disorders: A Randomized Double-Blind

Comparison w/Haloperidol

1998 Pfizer Pharmaceuticals, A Multi-Center, Placebo Controlled Double Blind

Study Comparing the Safety and Efficacy of Ziprasidone and Olanzapine in

Subjects with Schizophrenia or Schizoaffective Disorder Needing Inpatient Care.

1999 Janssen Pharmaceutica, Risperidone Depot vs. Placebo in the Treatment of

Subjects with Schizophrenia or Schizoaffective Disorder

1999 Development of a Model Psychopharmacology Curriculum for Psychiatric

Residents. (through the American Society of Clinical Psychopharmacology) $15,000

Supported in part by Lilly, Janssen and Zeneca Pharmaceuticals.

2000 National Institute of Mental Health, sub-contract (MH90001), Comparative $550,000

Effectiveness of Antipsychotic Medications in Patients with Schizophrenia

CATIE.

• Human Genetics Initiative

2001 Bristol-Myers Squibb, A Multicenter, Randomized, Double-Blind, Placebo

Controlled Study of Flexible Doses of Aripiprazole Versus Perphenazine

13

13

In the Treatment of Patients with Treatment-Resistant Schizophrenia.

2003 Otsuka, An Open-Label Follow-Up Study of the Long-Term Safety of

Aripiprazole in Patients with Psychosis.

2003 Pfizer, Zodiac International Schizophrenia Study to Compare the Cardiovascular

Safety of Ziprasidone and Olanzapine.

2003 Pfizer, A 12 Week Multicenter, Randomized, Double-Blind, Placebo Controlled

Evaluation of Donepezil Hydrochloride as Adjunctive Therapy in the Treatment

of Cognitive Impairment in Patient with Schizophrenia or Schizoeffective Disorder

2004 Oshima Education Fund $30,000

2004 Astra-Zeneca, Comparison of Atypicals for First Episode (CAFE)

2004 Bristol-Myers Squibb, The Treatment of Schizophrenia and OCD $80,000

Symptomatology with Aripirazole (investigator initiated study).

2004 Bristol-Myers Squibb, Efficacy and Weight Reduction Effects of

Aripiprazole in Stabilized Patients with Schizophrenia and Weight Associated $105,000

with Atypical Antipsychotics (investigator initiated study w/Reaven).

2005 American College of Neuropsychopharmacology, ACNP Public Outreach $ 5,000

Program

2005 GlaxoSmithKline, Lamictal vs Depakote Double Blind. (investigator initiated $120,000

study)

2005 Solvay Pharmaceuticals, Parallel-Group Efficacy and Safety Study

of Two Fixed Doses of Bifeprunox in the Treatment of Schizophrenia.

2005 Co-Investigator of a Harman Clinic Endowment Grant for a project

Fostering Collaboration Through Clinical Education: A Clinical

Neurosciences Seminar, Clinic and Curriculum Series in Child

Psychiatry and Pediatric Neurology (with Joshi SV, Chang KD and

Hahn J).

2006 Shire, An Open-Label Study of Equetro in Outpatients With Aggressive $125,000

Symptoms & Behavior (investigator initiated study)

2006 Bristol-Myers Squibb, A Multicenter, Randomized, Double-blind,

Placebo-controlled, 16-week Study of Aripiprazole Used as Dual Therapy

in the Treatment of Patients with Chronic Stable Schizophrenia or

Schizoaffective Disorder Demonstrating an Inadequate Response to

Quetiapine or Risperidone Monotherapy.

2006 Pfizer, A Multicenter, Double-Blind, Flexible-Dose, 6-month Trial Comparing

the Efficacy and Safey of Asenapine w/Olanzapine in Stable Subjects w/

Predominant, Persistent Negative Symptoms of Schizophrenia.

2006 CAMP (Foundation for NIH), Clinical Management of Metabolic $116,900

Problems in Patients w/Schizophrenia: Switching to Aripiprazole v. Continued

Treatment w/Olanzapine, Quetiapine, or Risperidone

14

14

2007 American College of Neuropsychopharmacology, ACNP Public Outreach $5,000

Initiative. 2007 Schizophrenia Education Day. (also supported by Lilly, Janssen,

Astra-Zeneca)

2007 Lundbeck, A Randomized, Double-Blind, Parallel-Group, Flexible-Dose Study

Exploring The Neurocognitive Effect Of Sertindole Versus Quetiapine In Patients

With Schizophrenia Using The MATRICS Consensus Cognitive Battery (MCCB).

2007 Pfizer, A Six Week, Double-Blind, Placebo-Controlled Phase III Trial Evaluating the

Efficacy, Safety, and Pharmacokinetics of Flexible Doses of Oral Ziprasidone in

Adolescents with Schizophrenia.

2008 Eli Lilly, United BioSource Corporation, Validation of the Reasons for Antipsychotic

Discontinuation/Continuation Questionnaire (RAD-Q) and Interview (RAD-I)

2008 Keeping Up With Advances in Psychopharmacology in the New Millenium, $4,000

four lectures at medical schools in Israel, supported by the Sarlo Fund and the

Ingrid D. Tauber Philanthropic Fund from the Jewish Community Endowment

Fund, San Francisco, June, 2008.

2008 Schizophrenia Trials Network associated with NIMH Contract (N01MH90001)

• Comparison of Optimal Antipsychotic Treatment for Schizophrenia (COATS: A Pilot Study)

• Metformin in the Treatment of Antipsychotic-Induced Weight Gain in Schizophrenia

(METS: A Pilot Study)

2008 Otsuka, A multicenter, Double-blind, Randomized, Active-controlled, Study to

Evaluate the Long-term Efficacy, Safety and Tolerability of an Intramuscular

Depot Formulation of Aripiprazole (OPC-14979) in Patients with Schizophrenia

(EU ASPIRE)

2009 ACNP, Educational Outreach Initiative Grant $5,000

2010- Multiple clinical trials of new medications for the treatment of mood disorders and schizophrenia,

at Pacific Research Partners, Oakland, CA. (list available on request)

Regional and National Professional Societies:

1965-1970 American Medical Association

1965- American Psychiatric Association

1971 Fellow

1985-92 Foundations' Fund Board for Research in Psychiatry

(Chair, 1985-92)

1999 Life Fellow

1999 Member, Committee on Research on Psychiatric Treatments,

Sub-committee on Antipsychotic Drugs & Diabetes Mellitus

2003 Northern California Psychiatric Society (NCPS)

• 2004-08 Committee on Awards

• 2009-12 Counselor-at-Large

++++++++++++++++++++++++++1970-1974 & American College of Psychiatrists

1990- 1990 Fellow

1996 -98 Committee on Honorary Fellowships

15

15

1970- Society of Biological Psychiatry

1991-93 Resource Development Committee

1997 Task Force on the Future of SBP

2001 George N. Thompson Award Committee, Society of Biological Psychiatry

1973- American College of Neuropsychopharmacology

1973 Scientific Associate

1978 Member

1980-84 Education and Training Committee, (Chair, 1982-84)

1984 Fellow

1984-90 Co-Chair, Committee to Develop a Model Curriculum in Psychopharmacology

1987-89 Committee on Problems of Public Concern

1989-91 Task Force on Coordinating Academic – Industry & Government Efforts

in Psychopharmacology

1989 & '96-98 Task Force on Psychotropic Drug Prescribing Privileges for Non-physicians

1988-92 Task Force on Scientific Misconduct

1994- Mentor, NIMH/Mead Johnson Minority Award Program

1995-97 Finance Committee (Chair, 1997-98)

2000-03 C+onstitution and Rules Committee (Chair, 2002-2004)

2005-09 Education and Training Committee

Co-Chair, 2005-7

2009-10 History Committee

2010-13 Public Information Committee

1973 Association for Academic Psychiatry, Charter Member

1978-80 Secretary

1983 Co-Chairman and Founder, Section on Residency Training

1983-84 Fellowship Committee

2008 Distinguished Life Fellow

1978 The Hastings Center-Institute of Society, Ethics and the Life Sciences

1978 American Family Therapy Academy

1982-84 Board of Trustees

1985 Committee on History of AFTA

1980 American Association of Psychiatric Administrators

1982 Association for Clinical Psychosocial Research, Founding Member

1982-85 Steering Committee

1988 Fellow

1984-94 Group for the Advancement of Psychiatry, Committee on the Family

1991 Program Committee

1992 Ad hoc Committee to Develop Practice Guidelines

1989 Psychiatric Research Society

1990 Collegium Internationale Neuro-Psychopharmacologicum (C.I.N.P.)

2002 CINP Regional Committee for North America

1992- Academia, Medicine & Psychiatric Foundation

1992 Fellow

1993- American Society of Clinical Psychopharmacology (A.S.C.P.), Founding Member

16

16

1993 - Model Curriculum Committee, Chair

1995 Work Group, Interface with Government & Industry, Clinical Trials Committee

1998 - Scientific Advisory Board

2001-2013 Treasurer

2005 Co-chair, Joint ASCP-AADPRT Curriculum Project

(with David Goldberg, MD)

2012 Finance Committee

1993- International Society for Sports Psychiatry, Founding Member

1993 - Chair, Scientific Program

1993 - Executive Board

2004 - 5 Chair, Nomination Committee

1997 West Coast College of Biological Psychiatry, Fellow

1998 Program Chair

1998 Pacific Rim College of Psychiatrists, Fellow

2011 World Affairs Council

Trustee, 2011-12

Education Committee, 2011-

2014 Collegium Internationale Neuropsychopharmacologie (CINP)

Education Committee, 2014-

Editorial and Advisory Boards:

1970-1981 Family Process

1981 Journal of Clinical Psychopharmacology

1981 Contemporary Family Therapy - An International Journal

1982- 2014 The Journal of Family Therapy (England)

1982-1995 Board of Advisors, Dickinson College

1984-1997 The Journal of Family Psychotherapy

1984-1987 National Council of Advisors on Development and External Affairs, UCSF

1989 Progress in Neuropsychology and Biological Psychiatry

1990-2 Advisory Board, MultiMedia Reviews in Psychiatry , Massachusetts General Hospital.

1993 Board Member, The National Mental Health Project

1993 Sertindole Advisory Board, , Neuroscience Venture, Abbott Laboratories

1995-1997 Gralnick Foundation Awards Committee

17

17

1996 CNS Science Advisory Board, Wyeth Ayerst Pharmaceutical

1997-9 Advisory Board, Janssen Pharmaceutica and Research Foundation

1997-9 Advisory Board, Institute for Healthcare Quality, Minneapolis

1997 Advisory Board, Zeneca Pharmaceuticals

1998 Advisory Board, Otsuka Pharmaceuticals

1999 Advisory Board, Hoechst Marion Roussel (Aventis)

1999 Advisory Board, NPSP Pharmaceuticals Bipolar Clinical Advisory Board, Boca Raton

2001, 5 Advisory Board, Pfizer (Geodon) Pharmaceuticals

2001 Board of Directors, National Foundation for Depressive Illness, Inc.

2002, 4, 5 Advisory Board, Shire Pharmaceuticals

2002, 3, 4, 5 Advisory Board, Bristol-Myers Squibb, California Neuroscience Advisory Board

2005- Editorial Board, The Journal of Clinical Psychiatry

2008- Editorial Board, The Physician and Sports Medicine

2009 Advisory Board, Pfizer. Anxiety Disorders

2011 Editorial Board, Revista Brasileira de Psiquiatria

2009 Scientific Advisory Board, Schizophrenia, Bristol-Myers Squibb

2012-2015 Member Data Monitoring Committee, VA Augmentation and Switching Treatment for Improving

Depression Outcome

2013 Scientific Advisory Board, Schizophrenia, Janssen Pharmaceuticals

2014 Editorial Board, CNS Spectrums

2014 Scientific Advisory Board, Schizophrenia, EnVivo Pharmaceuticals

2014 Consultant, Digital Psychiatry Educational Programs, Otsuka Americal Pharmaceuticals

2015 Consultant, National Football League

2015 Scientific Advisory Board, Schizophrenia, Forum Pharm. Boston, Mass.

18

18

CURRICULUM VITAE - PART II

Teaching Services

University of California, San Francisco 1968-78:

1975-1978 Director of Medical Student Education, Dept. of Psychiatry:

First Year Medical Students

1969-1970 (a) Behavioral Science and Psychopathology, Seminar Leader, Winter, 2 hrs/wk. Lecture,

"Psychophysiologic Disorders," given to entire class

1970 (b) Basic Clerkship 1-A. Supervisor, 2 hrs/wk, Spring

Second Year Medical Students

1968-1969 a) Psychiatry 121, Basic Psychiatry. Seminar Leader, 3 hrs/wk, Spring, Fall, Winter

1969-1970 b) Psychiatry 18, Behavioral Science and Psychopathology. Seminar Leader, 3 hrs/wk,

Fall Quarter; 2 hrs/wk, Spring Quarter, 1969-70. Course Coordinator, Spring, 1970

1972 c) Psychiatry 100, Psychopathology Course Committee, Course Coordinator and

Lecturer, 6 hrs/wk, Winter, 1972

1972 d) Psychiatry 101, Psychopathology Course Committee, Course Coordinator and

Lecturer, 6 hrs/wk, Winter, 1972

1973-1977 e) Psychiatry 100-101, Introduction to Clinical Psychiatry:

1972-73 Course Committee and Lecturer, 6 hrs/wk, Fall-Winter

1973-74 Course Coordinator and Lecturer, 6 hrs/wk, Fall-Winter

1974-77 Course Supervisor and Lecturer, 6 hrs/wk, Winter-Spring; Lecturer

Third Year Medical Students

1968- a) Psychiatry 110, Clinical Clerkship in Psychiatry. l hour/week, 1968-present;

Acting Director, Fall, 1977-78

Fourth Year Medical Students

1968-1978 a) Psychiatry 110, Clinical Clerkship in Psychiatry. 1 hour/week

1970-1975 b) Behavioral Specialist Pathway, Clinical Subpathway, Individual and Family

Therapy. Coordinator, 1 hour/week, Summer, Fall, Winter, Spring, 1970-75

Residents, Department of Psychiatry

1968-1978 a) Basic Psychiatry 1. Seminar Series Participant

1968-1978 b) Supervisor, 1st, 2nd, 3rd, and 4th Year Psychiatry Residents

1968-1978 c) Seminar on Hospital Psychiatry to Psychiatric Residents. 1 hour/week

19

19

1970-1972 d) Seminar, Family Dynamics and Therapy. 3 hrs/wk, Fall, ‘70; Spring, ‘71; Spring, ‘72

1969-1970 e) Clinical Psychiatry for Non-Psychiatrists. 2 hrs/wk, Fall-Winter

1968-1970 f) Paramedical Staff. 5 hrs/wk

1970 g) Committee to conduct qualifying examinations for admission to candidacy for PhD

degree, B. Tesher, Nursing, in the field of family therapy

1972-1973 h) The Teaching-Learning Process in Psychiatry. To Psychiatric Residents, Fall-Winter,

2 hrs/wk.

1973-1978 i) Coordinator, Basic Psychiatry II, to all Second Year Psychiatric Residents

1974-1977 j) Core seminar, Theory & Practice of Family Therapy, as part of Basic Psychiatry II, to

all second year psychiatric residents, 1974-75, 1975-76,1976-77 with David Kessler, MD

1976-1977 k) Seminar on Clinical Research Design, Elective, Third Year Psychiatric Residents

Cornell University Medical College - 1978-1993:

First Year Medical Students

1979 a) Understanding Human Behavior, Preceptor, 10 weeks, Fall

1980 b) Understanding Human Behavior, Lecturer and Panelist, Fall

1982 c) Investigative Approaches of Human Behavior, Preceptor, Spring

Third Year Medical Students

1978 a) Psychological Assessment of Medicine, Preceptor, Spring

1978 b) Core Clerkship, Preceptor, Summer

Other

1980-1993 a) Faculty Advisor

1980-1981 b) Internship Advisor

Faculty and Staff -- Department of Psychiatry

1978 a) Family Therapy Supervisory Seminar for Payne Whitney Faculty, 9 weeks, Spring

1978 b) Family Therapy Supervisory Seminar for Westchester Division Faculty, 9 weeks, Fall

1978 c) Seminar on Intro to Psychiatric Research for Payne Whitney Staff, 2 weeks, Fall

Residents: Department. of Psychiatry

20

20

Research Courses:

1980-1983 a) Introduction to Research, PGY II's, April-June

1980-1986 b) Intermediate Research Course, PGY lll’s, 10 weeks, January-April

1980-1986 c) Advanced Research Seminar, PGY IV's, 10 weeks, April-June

Psychopharmacology Courses

1982- a) Psychopharmacology Rounds, PGY II, III & IV's, 1982-present; Coordinator 1987-89

b) Psychopharmacology Consultant, to Inpatient Services, 1986-88, 1991-1993

1990-1993 c) Outpatient Psychopharmacology , PGY III's, 1990-present, weekly, all year

1990-1993 d) Psychopharmacology Supervision, PGY III's & IV's

Family Therapy Courses

1978-1993 a) Seminar on The Family Interview, PGY II Summer Course

1978-1993 b) Family Therapy-Inpatient Introductory Course, as part of PGY II Core Curriculum, 8 wks.

1979-1993 c) Family Therapy-Outpatient, for PGY III's as part of the Core Curriculum, Intermediate

Course, 8 weeks, Winter

1985-1993 d) Family Therapy, for PGY IV's, as part of Continuous Case Conference, Payne Whitney

Clinic, 12 weeks, Fall

1978 e) Seminar on Evaluation of the Family, as part of the Summer Orientation for PGY I's and II's

and Psychology Interns, Westchester Division, Summer

1978-1985 f) Introduction to Family Therapy, as part of Core Curriculum PGY II's, Westchester Division,

8 weeks (90 min.), Winter

1978-1980 g) Continuous Case Conference on Family Therapy, for the Child Psychiatry Service.

Bimonthly, September to June

Hospital Psychiatry Courses

1978-1993 a) Criteria for Selection of Inpatient Treatment Modalities, as part of PGY II Core Curriculum.

6/hours/yearly

b) Inpatient Psychiatry, for PGY II's, 3 weeks, Summer, (yearly).

1980-1984 c) Assistant Unit Chief Clinical Rounds, PGY IV's, Payne Whitney Clinic, biweekly

1991- d) Psychopathology Course, Schizophrenia to PG II's

General Psychiatry Courses

1978-1993 a) Psychiatric Resident Tutorial, Payne Whitney Clinic, 6/hours/yearly

1980-82 b) Supervisor, Long Term Psychotherapy, PGY II's

21

21

Stanford University School of Medicine - 1993 - present:

General Psychiatry Courses

1993-94- a) Psychopathology course, PGY II, Treatment Modules on Schizophrenia & Bipolar Disorder

1994-95- b) PGY IV Board Review Course, Schizophrenia Module

1993-98 c) Chairman's Rounds

Hospital Psychiatry Courses

1993- a) Inpatient Medical Student and Resident Supervision

1994-98 b) Inpatient Psychiatry, Course Coordinator and Lecturer, PGY II

• Overview

• Workup and Treatment Planning

• Treatment of Psychosis

Psychopharmacology Courses

1994 Introduction to Psychopharmacology, PG II,

2002 -Personality Disorder

2003 - Bipolar Disorder, Medication and Compliance Issues

1995---2013 Strategies of Outpatient Psychopharmacology, PG III, Course Coordinator and lecturer:

• Schizophrenia

• Combining & Integrating Psychotherapeutic Intervention with Medication

• Art of Psychopharmacology

2014-15- , Lecturer:

- Comparative Effectiveness Studies: Schizophrenia

-Emerging Antipsychotics and Off-Label Use of Antipsychotics

-Ethical Issues in Psychopharmacology

2004 Neuroscience, PG III

Lecture, Metabolic Side Effects of Antipsychotics

2005--2013 Introduction to Psychopathology and Psychopharmacology, PG II, 4 quarters/year, Course

Director (with Sara Mueller, MD and Sallie DeGolia, MD) and Lectures:

• History of Psychiatric Treatments

• Personality Disorders

2011- Overview of Psychiatry, PGY I

Lecture, Schizophrenia

Medical School Courses

Winter, 2001-02, Medical School Clerkship, Psychotic Disorder and Neuroleptic Treatment.

Outside UCSF, Cornell University Medical College & Stanford University

22

22

1965-1966 Columbia University, College of Physicians and Surgeons. Basic Clinical Psychiatry, to Third

Year Medical Students, Fall-Winter, 3 hrs/wk.

1964-1966 Hillside Hospital. Supervision and Teaching, First and Second Year Psychiatric Residents,

15 hrs/wk, all year.

1966-1968 U.S. Army Hospital Specialized Treatment Center. Ft. Gordon, Georgia. Basic Psychiatry I,

to Medical and Paramedical Staff, l hr/wk, all year.

1966-1968 Medical College of Georgia. Family Therapy, to Psychiatry Dept. Staff, Residents, and Medical

Students, 2 hrs/wk, 20 wks/yr

1970-1978 Mt. Zion Hospital and Medical Center. Seminar in Psychopharmacology, Psychosomatic

Conference, to Second and Third Year Psychiatry Residents, two 90-minute sessions yearly

1986 School of Medicine, University of Verona. Seminar on Recent Developments in American

Psychiatry, to Psychiatric Residents and Faculty, January-June, six 90 minute sessions

23

23

COMMITTEE SERVICE

University Of California, San Francisco, School of Medicine

Department of Psychiatry Committees:

1968-1970 Chairman, Public Health and Safety Committees, Langley Porter Institute

1968-1970 Research Committee, Clinical Research Ward, Langley Porter Institute

1969 Course Committee, Freshman Psychiatry Course, Dept. of Psychiatry

1969 Annual Graduation and Departmental Meeting, Langley Porter Institute

1969-1970 Ad Hoc Committee on Residency Training, Langley Porter Institute

1969-1978 Course Committee, Sophomore Psychiatry Course, Dept. of Psychiatry

1970 Ad Hoc Committee on Outpatient Psychiatric Care, Dept. of Psychiatry

1971-1973 Residency Selection Committee, Langley Porter Institute

1971-1973 Residency Training Committee, Langley Porter Institute

1972 Noon Conference Committee, Langley Porter Institute

1973 Building Committee, Langley Porter Institute

1973-1978 Departmental Committee on Medical Student Education, Dept. of Psychiatry

1973-1976 Review Committee for Appointments and Promotions of Regular Faculty, Dept. of Psychiatry

1974-1975 Staff Affiliate Review Committee, Langley Porter Institute

1974-1978 Committee on Academic Affairs, Dept. of Psychiatry, School of Medicine, UCSF

1975-1978 Departmental Task Force on Revision of Medical Student Curriculum, Dept. of Psychiatry

1976-1978 Administrative Planning Team, Langley Porter Institute

1976 Ad Hoc Committee for Alexander Simon Award, Dept. of Psychiatry

1976 Subcommittee for Basic Curriculum, Residency Training, Dept. of Psychiatry

1976-1978 Interdisciplinary Education Committee, Dept. of Psychiatry, School of Medicine

1976-1978 Medical Student Education Committee, Dept. of Psychiatry, School of Medicine

School of Medicine Committees

1973-1978 Curriculum Committee

1974-1978 Subcommittee on Evaluation

1974-1975 Basic Clinical Course Operations Subcommittee1974; Acting Chairman, 1975

1974 Screening and Promotions Committee

1975-1976 Search Committee, Director of Psychiatric Nursing, 1975-76

Cornell University Medical College:

Department of Psychiatry Committees

1978-1988 Inpatient Steering Committee

1978-1980 PGY II Education Committee

1978-1993 Family Therapy Planning Group, 1978-1993

1979-1983 PGY IV Education Committee

1978-1993 Departmental Research Committee- Chairman, 1981-83; Steering Committee, 1992-1993

1981-1983 Computer Committee

1981-1983 Media Committee

1983-1988 Residency Training Committee

1991-1993 Residency Training Committee

1985-1988 Fellowship Selection Committee

1984-1986 Space Committee

1987-1988 Executive Committee

1990-1993 Executive Committee

1990 Task Force on Vertical Services

24

24

1990-1993 Formulary Committee

1990-1993 Appointments and Promotions Committee

Stanford University School Of Medicine:

Departmental Committees

1993-2000 Executive Committee

1993- Residency Training Committee

1993-95 Credentials Committee, Chairman

1996-2005 Appointment & Promotions

Chair, 1999 – 2005

Hospital Committees

1993-2000 Inpatient Management Committee

1993-2000 Operations Improvement Committee

1993-2000 Psychiatry Business Plan Committee

1993-2000 Clinic Executive Committee

1998-2000 UCSF/Stanford Merger -

Brown & Toland Medical Group Mental Health Executive Committee

Mentoring

2008-9 Jacob S. Ballon, M.D., American Psychiatric Institute for Research & Education

(APIRE)

25

25

Curriculum Vitae – Part III COMMUNITY AND PUBLIC SERVICE

Presentation of paper "Psychophysiologic Factors in the Etiology of Preeclampsia," American Psychosomatic

Society, April 1964.

Grand Rounds, "Psychophysiologic Factors in the Etiology of Schizophrenia," to the Dept. of Psychiatry, Mt. Zion

Hospital, San Francisco 1964.

Grand Rounds, "Psychophysiologic Factors in the Etiology of Schizophrenia," to the Dept. of Obstetrics and

Gynecology, Mt. Zion Hospital, 1964.

Presentation of paper, "Mood and Behavioral Changes Associated with the Use of the Oral Contraceptive Agents:

A Review of the Literature," Eighth Annual Psychiatric Research Society Meeting, 1965.

Presentation of paper, "The 'Sick' Family and Schizophrenia - Cause and Effect?" to the Tenth Annual Psychiatric

Research Society Meeting, Cincinnati, 1967.

Institute Leader, "Family Dynamics and Treatment," Annual Meeting, Georgia Branch, National Association of

Social Workers, February 1967.

Invited Lecture, "The Place of Occupational Therapy in Clinical Psychiatric Treatment," Georgia Occupational

Therapy Association, 1967.

Institute Leader on "Family Therapy and Hospital Psychiatry," at Columbia, S.C., VA Hospital September 1967

Invited Lecture, on "The School and the Family," to the Annual Meeting of the Georgia Association of Visiting

Teachers, Augusta, Georgia, November 1967.

Seminar Leader on "Family Therapy," at Macon, Ga., Mental Health Clinic, Macon, Ga., November 1967.

Invited Address, "The Changing Role of the Family," Unitarian Fellowship, Augusta, Ga., December 1967.

Invited Lecture, "Basic Clinical Psychiatry" to Psychology Students, Paine College, Augusta, Ga., (Jan)1968.

Lecture and Panel Discussion, "The Role of the Clergy in Family Counseling, at a seminar on Family Counseling,

Augusta, Ga., February 1968.

Address, "The Family and Southern Society," to First Mt. Moriah Baptist Church, Augusta, Ga., April 1968.

Film Presentation: Videotape Playback in Family Therapy (with G. Marshall) 16mm. B & W 10 min. Presented at

the 1968 annual meeting, American Psychiatric Association, Boston, Mass. May 16, 1968

Grand Rounds, "Mood and Behaviorial Changes Associated with Use of Oral Contraceptives," OBGYN, University

of California, San Francisco, September 1968.

Participant, panel on Training of Family Therapists, Don D. Jackson Memorial Family Conference, Asilomar,

California, February 1969.

Lecture on "Current Status of Family Therapy," given to Association of Family Therapists, San Francisco, 3/69.

Film and Seminar Discussion on "An Introduction to Family Therapy," given at the Clinical Seminar Series, Langley

Porter Neuropsychiatric Institute, Psychology Dept., March 1969.

26

26

Two-Day Seminar on Current Developments in Psychiatry given at Dept. of Psychiatry, Medical College of

Georgia, May 1969.

Film "Family Therapy: An Introduction," presented at the Annual Meeting, American Psychiatric Association, Miami

Beach, Fla., May 1969.

Discussion of paper entitled "Psychosexual Responses to Ileostomy and Colostomy" at American Psychiatric

Association Meeting, Miami Beach, Fla., 1969.

Film "Family Therapy: An Introduction," shown at Staff Meeting, Mental Research at Ninth Western Divisional

Meeting 1969, of Westen Psychiatric Association, Seattle, August 1969.

Moderator of Panel on Family Therapy: Rationale, Methods, Teaching and Research at Ninth Western Divisional

Meeting 1969, of Western Psychiatric Association, Seattle, August 1969.

Discussion of Paper, "The Psychiatrist as Counselor and Friend to the Family," by Herbert C. Wimberger, MD, at

Ninth Western Divisional Meeting, Western Psychiatric Association, Seattle, August 1969.

Abstracts Editor, Family Process, July 1964-78.

Participant in CBS News Reports Program titled "The Pill," KPIX, February 1970.

Participant on Panel: "Therapists and Families," American Orthopsychiatric Association 47th Annual Meeting in

San Francisco, March 1970.

Lecture on "Issues in Family Therapy Training," presented to Interdisciplinary Training Program Seminar, Napa

State Hospital, May 1970.

Moderator of Panel, "Issues in Training of Family Therapists," American Psychiatric Association Annual Meeting,

May 1970.

Discussion Leader, NIMH Career Teachers in Psychiatry Meeting, Boston, October, 1971

Participant In Panel, "Emotional Problems of Psychiatric Residents," American Psychiatric Association Annual

Meeting, May, 1972.

Presentation of paper entitled "Management of Psychoses Associated with Dialysis," American Psychiatric

Association Annual Meeting, May 1972.

Regional Coordinator, "The Psychiatrist as Teacher," for the National Conference on Teaching Psychiatry, one-day

regional meeting held at San Francisco, May 1972.

Presentation of Paper and Participant on Panel, "Stress Events & Psychiatric Illness," at the

Symposium"Stress: Its Impact on Thought and Emotion," University of California at San Francisco, June 1972

Group Leader, Regional Coordinator, and Presentation at "Free University" of film on Family Therapy at the

national conference, "The Psychiatrist as a Teacher." Airlie House, October 3-6, 1972.

Lecture, "Transference and Countertransference," to Graduate Psychiatric Nursing Students, University of

California, San Francisco, November 1972.

Resource Teacher in Section on "University Dept. of Psychiatry" at the First National Conference on Training in

Family Therapy, Philadelphia, November 30 - December 2, 1972.

27

27

Lecture, "Depression," presented as part of a section entitled "Dilemmas in Therapy" as part of the 23rd Annual

Course for Physicians in General Practice, Mt. Zion Hospital and Medical Center, February 1973.

Presentation of paper, "Short vs. Long Hospitalization: A Prospective Controlled Study -- Preliminary Results of a

One-Year Follow-up of Schizophrenics," Research Seminar, Dept. of Psychiatry, Mt. Zion Hospital, April 1973.

Presentation of paper, "Short vs. Long Hospitalization: A Prospective Controlled Study -- Preliminary Results of a

One-Year Follow-up of Schizophrenics," at the Annual Meeting, American Psychiatric Association, Honolulu,

Hawaii, May, 1973.

Presentation of paper, "Indications and Relative Contraindications for Family Treatment, Circa 1973," at the San

Francisco Family Forum, San Francisco General Hospital, January 10, 1974.

Presentation of paper, "Treatment and Outcome in Schizophrenia," at the Merger Celebration in Honor of the Merger

of Langley Porter Neuropsychiatric Institute with University of California, San Francisco, February, 1974.

Presentation of paper, "Indications and Contraindications for Family Therapy," at the Nathan W. Ackerman

Memorial Conference, Venezuela, February, 1974.

Film presentation, "Family Therapy: An Introduction:" 1971: 12 showings 1972: 8 showings

1973: 8 showings 1974: 6 showings

Discussant, Conference, "Lithium: Its Role in Manic-Depressive Illness," Chief's Conference, Dept. of Psychiatry,

Mt. Zion Hospital, San Francisco, March 12, 1974.

Presentation of paper, "Short Versus Long Psychiatric Hospitalization for Schizophrenia - Preliminary Results, One

Year Followup," Noon Conference, Langley Porter Neuropsychiatric Institute, San Francisco, 3/74.

Presentation of paper, "Mood and Behavioral Changes Associated with the Use of Oral Contraceptives," 1st World

Congress of Biological Psychiatry, Buenos Aires, Argentina, September, 1974.

Presentation of paper, "Short Versus Long Psychiatric Hospitalization: A Controlled Study," Dept. of Psychiatry

Grand Rounds, Cornell University Medical College, New York, NY, November 1974.

Presentation of paper, "Short Versus Long Psychiatric Hospitalization: A Controlled Study," SUNY, Downstate

Medical Center, New York, NY, November 1974.

Coordinator, "The Role of the Family in Medical Practice," Third National Workshop on Psychiatric Education,

Association for Academic Psychiatry, Chicago, Illinios, November 1974.

Presentation of paper, "Short Versus Long Hospitalization - A Prospective Controlled Study: One Year Followup

Results," Section on Interaction of Drugs and Nonsomatic Therapies, American College of

Neuropsychopharmacology, Puerto Rico, December 1974.

Presentation of paper, "Short Versus Long Hospitalization: A Prospective Controlled Study. IV-A. One Year

Followup Results for Schizophrenics," Research Conference, Dept. of Psychiatry, Mt. Zion Medical Center, San

Francisco, February 18, 1975.

Panel Discussant, "The Treatment of Schizophrenia at Langley Porter Institute," Noon Conference, Langley Porter

Institute, San Francisco, April 30, 1975.

Panel Moderator, "Controlled Studies of Alternative Lengths of Hospitalization for Psychiatric Illness," presented at

the 1975 Annual Meeting, American Psychiatric Association, Anaheim, California, May 1975.

28

28

Presentation of paper, "Short Versus Long Hospitalization: A Prospective Controlled Study. IV. One Year Followup

Results for Schizophrenics," American Psychiatric Association Annual Meeting, Anaheim, CA, 5/75.

Radio presentation, "Loxitane in Schizophrenia," CBS Radio Network, July 12 and 13, 1975.

Discussant, "Conceptual Approaches to Schizophrenic Disorder," Grand Rounds, Dept. of Psychiatry, University of

California, San Francisco, September 22, 1975.

Discussant, "Depression in Medical Practice," Grand Rounds, Dept. of Medicine, University of California, San

Francisco, September 23, 1975.

Presentation of paper, "Short Versus Long Hospitalization: A Prospective Controlled Study. II. Results for

Schizophrenic Inpatients," Langley Porter Institute weekly research staff conference, October 10, 1975.

Panelist, "Can a Psychiatric Hospital Survive Mental Health and Marijuana?" Grand Rounds, Dept. of Psychiatry,

UCSF, November 18 and 25, 1975.

Seminar Leader, "Issues in Family Therapy," California Branch District Meeting American Psychiatric Association

Conference, Palm Springs, November 1975.

Presentation of paper, "Short VersusLong Psychiatric Hospitalization: A Controlled Study. Medication and Outcome

for Schizophrenics," American College of Neuropsychopharmacology, Puerto Rico, December 1975.

Exhibit, entitled "A Teaching Package for a Preclinical Psychiatry Course," 30th All-University Faculty Conference,

University of California, Santa Barbara, March 25-27, 1976.

Discussant and Presentation of paper, "Short Versus Long Psychiatric Hospitalization," as part of a

symposium: "A Critical Appraisal of Community Psychiatry," Kittay Scientific Foundation, NY, 3/76.

Presentation of paper, "Controversial Premises of Marital and Family Therapy," (with David R. Kessler, MD) for the

San Francisco Family Forum, Family Health Center, San Francisco General Hospital, April 15, 1976.

Presentation and Discussion, "Short Versus Long Psychiatric Hospitalization: A Controlled Study, Two Year

Results," Grand Rounds, Dept. of Psychiatry, UCSF, April 20, 1976.

Panelist, "Schizophrenia -- Which Treatment and For Whom," 1976 Annual Meeting, American Psychiatric

Association, Miami, May 1976.

Panelist, "What Makes Medical Students So Difficult To Teach?" 1976 Annual Meeting, American Psychiatric

Association, Miami, May 1976.

Panelist, "Controversies in Psychiatric Education," 1976 Annual Meeting, American Psychiatric Association, Miami,

May 1976.

Presentation of paper, "Increasing Learning During the Psychiatric Residency," (with Leon Epstein, MD) 1976

Annual Meeting, American Psychiatric Association, Miami, May 1976.

Presentation of paper, "Indications and Contraindications for Family Therapy; Changing Concepts," Psychiatry

Grand Rounds, Dept. of Psychiatry, School of Medicine, U.C. Davis, September 1976.

Presentation of paper, "Short Versus Long Psychiatric Hospitalization: A Controlled Study: Two Year Results,"

Dept. of Psychiatry, Mt. Sinai School of Medicine, New York, September 1976.

Presentation of paper, "Short Versus Long Psychiatric Hospitalization: Final Results and Treatment Implications,"

Dept. of Psychiatry, Mt. Zion Hospital and Medical Center, San Francisco, October 1976.

29

29

Keynote Speaker, "Short-Term Intensive Psychiatric Hospital Treatment: Which Treatment and for

Whom?" National Conference on Short-Term Intensive Psychiatric Hospital Treatment, Scottsdale, AZ, 11/76

Panel Moderator, "Treating the Impaired Physician: Confidentiality vs. Responsibility," presented at the 1976

Annual Meeting, Association of American Medical Colleges, San Francisco, November 1976.

Examiner, American Board of Psychiatry and Neurology, Seattle, February 1977.

Special Lecture, "A Teaching Package for a Preclinical Psychiatry Course," Dept. of Psychiatry, College of

Physicians and Surgeons, Columbia University, New York, February 1977.

Presentation of paper, "Short Versus Long Psychiatric Hospitalization: A Controlled Study," Grand Rounds, Dept.

of Psychiatry, University of New Mexico, Albuquerque, New Mexico, March 1977.

Presentation of paper, "Indications and Contraindications for Family Therapy," Grand Rounds, Veterans

Administration Hospital, Albuquerque, New Mexico, March 1977.

Referee, Journal of Nervous and Mental Diseases, Archives of General Psychiatry, American Journal of

Psychiatry, and Family Process. Hospital and Community Psychiatry.

Presentation of paper, "The Architectural Design of a Psychotherapeutic Milieu," 1977 Annual Meeting of the

American Psychiatric Association, Toronto, Canada, May 1977.

Panelist, "New Directions in Family Research: Ritual, Real Time and Images," 1977 Annual Meeting of the

American Psychiatric Association, Toronto, Canada, May 1977.

Panel Moderator, "Schizophrenia - Which Treatment and For Whom?", 1977 Annual Meeting of the American

Psychiatric Association, Toronto, Canada, May 1977.

Panelist and Discussion Group Leader, at conference entitled "Families In Contemporary America: Varieties of

Form, Function and Experience," jointly sponsored by the Dept. of Psychiatry and Behavioral Sciences of the

George Washington University School of Medicine and the Center for Continuing Education in Mental Health of

the Psychiatric Institute Foundation, Washington, D.C., June 1977.

Television Presentation, Role of Clinical Psychiatry - on "The Hidden Universe" - ABC National Television

Documentary, June 1977.

Presentation of paper, "Short Versus Long Psychiatric Hospitalization," World Psychiatric Association, Honolulu,

August 1977.

Presentation of paper, "Indications and Contraindictions for Family Therapy," as part of an invited seminar on

Family Therapy, World Psychiatric Association, Honolulu, August 1977.

Advisory Editorial Board Member, International Journal of Family Therapy, as of September 1977. Psychiatric

Quarterly, 1980.

Discussant, "The Premenstrum: A Psychological Investigation," Grand Rounds, Dept. of Psychiatry, University of

California, San Francisco, November 22, 1977.

Presentation of paper, "Development of a Curriculum and of a Faculty for Medical Student Education in

Psychiatry," The Annual Meeting of the Association of Academic Psychiatry, New Orleans, January 1978.

Presentation of paper, "A New Drug Treatment for Premenstrual Psychosis," Poster Session, The Annual Meeting

of the American Psychiatric Association, Atlanta, Georgia, May 1978.

30

30

Organizer, Special Session, "Treating the Impaired Physician: Confidentiality and Responsibility," The Annual

Meeting of the American Psychiatric Association, Atlanta, Georgia, May 1978.

Presentation of paper, "Hospitals in the 1980s: Service, Training and Research," Presented as part of the Special

Session, "Hospital Treatment of Emotional Disorders: Circa, 1978, at the Annual Meeting of the American

Psychiatric Association, Atlanta, Georgia, May 1978.

Lecture and Discussion, "Indications and Contraindications for Family Therapy: Circa, 1978," at Grand Rounds,

Dept. of Psychiatry, The New York Hospital-Cornell University Medical College, May 17, 1978.

Presentation of paper, "Research in Occupational Therapy," at a Conference entitled, "A Revitalization Movement

within Occupational Therapy" sponsored by Metropolitan New York District, New York State Occupational Therapy

Association. May 1978.

Presentation and Discussion, "Family Therapy & Crisis/Loss,"Memorial Hospital, New York, November 2, l978.

Presentation and Discussion, "The Hospital Management of the Suicidal Patient," at a Symposium: "The Suicidal

Patient: Identification and Treatment," sponsored by Dept. of Psychiatry, Albany Medical College, March 28, 1979,

Albany, New York.

Presentation and Discussion, "Psychiatric Problems in General Practice," as part of a Symposium: "Common

Medical Problems in Office Practice," sponsored by the Continuing Education Committee of St. Vincent's Hospital,

Santa Fe, N.M., March 30, 1979.

Presentation and Discussion, "Effects of Divorce on the Family," as part of a Symposium, "Divorce and the

Patient," Sponsored by Continuing Education Committee of St. Vincent's Hospital, Santa Fe, N.M., 3/79.

Presentation of paper, "Short Versus Long Psychiatric Hospitalization: A Controlled Study -- Final Results," Grand

Rounds, McLean Hospital, Boston, Massachusetts, April 1979.

Presentation of paper, "A New Drug Treatment for Premenstrual Exacerbation of Schizophrenia" at Harvard

Medical School, Dept. of Psychiatry, Boston, Massachusetts, April 1979.

Presentation of paper, "The Physician's Family: Approach to Impairment," as part of a Symposium, "The Impaired

Physician: Prevention and Treatment," at the Annual Meeting, American Psychiatric Association, Chicago, May

1979.

Discussant, "Psychotherapy Supervision," at the American Psychiatric Association's Annual Meeting, Chicago,

May 1979.

Presentation, "Short Hospital Stay is Better than Long Hospital Stay?" "Pro Position" at the 31st Institute on

Hospital and Community Psychiatry, September 3-6, 1979, New Orleans.

Presentation, "Future Directions in Hospital Psychiatry," keynote speech, Dept. of Psychiatry, at Alumni Teaching

Day, Long Island Jewish-Hillside Medical Center, Glen Oaks, New York, September 1979.

Grand Rounds, "The Family Model in an Inpatient Setting," Dept. of Psychiatry, North Shore Hospital, Manhasset,

New York, October 1979.

Grand Rounds, "The Family Model in an Inpatient Setting," Dept. of Psychiatry, Albert Einstein College of

Medicine, New York, NY, October 1979.

Grand Rounds, "Family Therapy -- Indications and Contraindications," Dept. of Psychiatry, City Hospital Center at

Elmhurst, October 1979.

31

31

Grand Rounds, "Psychiatric Hospitalization for the 1980s: A Controlled Study of Short Versus Long Hospitalization,

Final Results," Dept. of Psychiatry, Cornell University Medical College, April 1980.

Invited Paper, "Psychiatric Aspects of Basketball," Psychiatric Annals Volume 10, Number 3:108-112, 1980.

Organizer of Continuing Medical Education Seminar, titled, "Hospital Treatment: Which Treatment and How Long

for Which Patients?" Cornell University Medical College, Dept. of Psychiatry, April 1980.

Presentation on "The Role of Psychoanalysis in Family Therapy," as part of a Continuing Medical Education

Course entitled, "The Role of Psychoanalysis in Contemporary Psychiatry," at Cornell University Medical College,

Spring, 1980.

Discussant for Symposium, "Enhancing Treatment Compliance," at the Annual Meeting of the American

Psychiatric Association, San Francisco, 1980.

Presentation on "Leadership in the Hospital," as part of a Course on "Leadership," at the Annual Meeting of the

American Psychiatric Association, San Francisco, 1980.

Presentation on "Family Therapy and the Treatment of the Child" at the weekly Child-Adolescence Staff Meeting,

Dept. of Child Psychiatry, Mt. Sinai Hospital, November 1980.

Participant, on Radio Program, "Conference Call: Parents & Children, WABC, November 30, 1980, New York.

Grand Rounds, "Psychiatric Hospitalization for the 80s," St. Joseph's Hospital and Medical Center, Paterson, New

Jersey, February 1981.

Keynote Speaker, "Illness and the Impact on Family Systems," at a Symposium entitled "Illness and the Family,"

sponsored by La Tortuga & Sherman Clinic, Santa Fe, March 198l.

Presentation of paper, "Thinking Disorder in Depression: Longitudinal Results" (with Braff D, Griffin P), and

"Outcome of Irregularly Discharged Mental Patients" (with Braff D, Johnson G), for the American Psychiatric

Association Annual Meeting, New Orleans, May 1981.

Consultant for Departmental Planning, Dept. of Psychiatry, Mt. Zion Hospital, San Francisco, CA , June 1981.

Chapter Consultant, Family Therapy, American Psychiatric Assn. Commission on Psychiatric Therapies, 1981.

Grand Rounds, "Short Vs Long Hospitalization: Final Results," State University of New York, Syracuse, NY, 9 /81.

Grand Rounds, "Treating the Hospitalized Schizophrenic Patient and Family," Rockland Psychiatric Center,

Orangeberg, New York, October 1981.

Presentation, "Short Versus Long Hospitalization for Schizophrenia," World Psychiatric Association/APA Regional

Meeting, New York City, November 1981.

Chairman, Education Committee and session on the "Teaching of Psychopharmacology," Annual Meeting,

American College of Neuropsychopharmacology, San Diego, December 1981.

Presentation, "The Family Model in an Inpatient Setting," Family Study Group, SUNY, Downstate Medical Center,

January 1982.

Presentation of paper, "Duration of Hospitalization as a Variable in Outcome," (John F. Clarkin, PhD and Ira

D. Glick, MD), The National Association of Private Psychiatric Hospitals, Scottsdale, Arizona, January 1982.

32

32

Panelist, "Family Therapy of Suicidal Behavior," Annual Meeting of Assn. of Suicidology, New York City, 4/82.

Presentation of paper, "Thought Disorder and Depression in Psychiatric Patients," (David L. Braff, MD and Ira

D. Glick, MD) for the Western Psychological Association Annual Meeting, Sacramento, CA, April 1982.

Panelist, "The Widening Scope of Family Therapy," Annual Meeting of the American Psychiatric Association,

Toronto, Canada, May 1982.

Presentation of paper, "Which Chronic Patients Mostly Need Readmission," (with Braff D, MD, Klar H, MD), for the

Annual Meeting of the American Psychiatric Association, Toronto, Canada, May 1982.

Discussant, Conference on "The Changing American Family," The 67th Annual Seymour Silverberg Lecture, Long

Island Jewish-Hillside Medical Center, June 1982.

Keynote Address, "Couples in the 1980s: Emerging Trends," Workshop on "Step-Parenting," and Panel

Discussion - all at the Symposium, "Marital and Sexual Therapy," The Family and Couples Institute, The Dept. of

Psychiatry, Tufts University School of Medicine, Boston, June 1982.

Presentation of Research Project, "Inpatient Family Intervention: A Controlled Study" and Presentation of "The

Family Therapy Training Program at PWC" at the 1982 Annual Meeting, American Family Therapy Association,

Boston, June 1982.

Invited Guest, Interviewed on topic of "Vacations & Couples," on Travel Talk, Dena Kaye, WMCA, NYC, 10/82.

Invited Lecturer, "The Changing American Family: Emerging Trends and Comparison with the Japanese Family,"

Dept. of Psychiatry, Juntendo University, Tokyo, October 1982.

Grand Rounds, "Toward the Definition and Delivery of Mental Health Care," Massachusetts Mental Health Center,

Boston, October 1982.

Grand Rounds, "Guidelines for Family Therapy," Dept. of Psychiatry, Medical College of Georgia, 1/83.

Grand Rounds, "Guidelines for Family Therapy," Dept. of Psychiatry, Tulane University and Louisiana State

University, February 1983.

Presentation of paper, "Teaching Investigative Psychiatry to Psychiatric Residents, a Sequential

Curriculum: Everything You Wanted to Know About Research, But Were Afraid To Ask." Free University

Presentation, at the Annual Meeting of the Association for Academic Psychiatry, Tampa, March 1983.

Presentation of paper, "A New Drug Treatment for Premenstrual Schizophrenia," at the Eleventh Annual

Conference on Psychosomatic Obstetrics and Gynecology, Sugar Loaf, Temple University Conference Center,

Philadelphia, March 1983.

Visiting Scholar, Dept. of Psychiatry, School of Medicine, University of Vermont, Burlington, March 1983.

Grand Rounds, "Psychiatric Hospitalization for the 1980s," Dept. of Psychiatry, School of Medicine, UCLA and

Harbor Hospital, Los Angeles, April 1983.

Grand Rounds, "Toward the Definition and Delivery of Mental Health Services: Who Should Pay and for What?"

Dept. of Psychiatry, UCSF, San Francisco, April 1983.

Invited Paper, "Treatment of Severe Premenstrual Syndrome (PMS) and Premenstrual Exacerbation of Psychiatric

Disorder," Premenstrual Syndrome Workshop, co-sponsored by Center for Studies of Affective Disorder,

Psychobiological Processes & Behavioral Medicine Section, Clinical Research Branch, and the Intramural

Research Program, NIMH, April 1983.

33

33

Presentation, "Treatment of Dual Doctor Couples," as part of an APA Issue Workshop, "Dual Doctor Couples" at

the Annual Meeting of the American Psychiatric Association, New York, May 1983.

Co-Chair and Presentation, "Overview" for Component Presentation, "Obstacles to Quality Clinical Systems,"

presented by APA Committee on Administrative Psychiatry, at the Annual Meeting of the American Psychiatric

Association, New York, May 1983.

Presentation and Co-Moderator, APA Issue Workshop, "Family Therapy Training in Residency Programs," at the

Annual Meeting of the American Psychiatric Association, New York, May 1983.

Presentation, "The Basics of Family Treatment" (with Henry Grunebaum, MD), as part of "Psychiatry

Update," at the Annual Meeting of the American Psychiatric Association, New York, May 1983.

Presentation, "Review of Length of Stay Research," as part of a course, "Inpatient Treatment Programs:

Programs: Acute and Long-Term," at the Annual Meeting of the American Psychiatric Association, NY, 5/83.

Presentation of paper, "The Importance of Thought Disorder in Depressives" (with David Braff, MD), at the Annual

Meeting of the American Psychiatric Association, New York, May 1983.

Presentation of paper, "Inpatient Family Intervention: A Controlled Study," at the Annual Meeting of the American

Psychiatric Association, New York, May 1983.

Presentation of Research Project, "Inpatient Family Interventions: A Controlled Study" and Presentation of "The

Family Therapy Training Program at PWC" at the 1983 Annual Meeting, American Family Therapy Association,

San Francisco, California, June 1983.

Grand Rounds, "Psychiatric Hospitalization for the 1980s," Bergen Pines County Hospital, Paramus, NJ. 6/83.

Presentation, "Inpatient Family Intervention: A Controlled Study," at the Annual Meeting of the American

Psychological Association, Anaheim, California, August 1983.

Grand Rounds, "When Should the Chronic Patient be Hospitalized," Dept. of Psychiatry, St. Luke's/Roosevelt

Hospital Center, New York, September 1983.

Distinguished Lecturer, "Doing Research Without Pain," University of Medicine and Dentistry of NJ, 101/83.

Lecture, "Diagnosis and Treatment of Depression," as part of a course, "Recent Advances in Medicine," Temple

University School of Medicine, Philadelphia, November 1983.

Co-Chairman, ACNP Training Session, "Issues in Clinical Psychobiologic-Psychopharmacologic Research

Training," Annual Meeting of the American College of Neuropsychopharmacology, San Juan, 1983.

Grand Rounds, "Toward the Definition of and Delivery of Mental Health Services - Who Should Pay and for

What?" The New York Hospital-Cornell University Medical College, January 1984.

Grand Rounds, "The Changing Role of the Hospital in Treatment of the Chronic Patient," Roosevelt Hospital, New

York, February 1984.

Invited Lecturer, "Focus on Family Psychotherapy Advances" and "Practical Office Psychotherapy," Winter

Update, Dept. of Psychiatry, University of South Dakota, February 1984.

Free University Presentation, "Teaching Integration of Psychiatric Models to Residents," at the Annual Meeting of

the Association of Academic Psychiatrists, Tampa, March 1984.

34

34

Grand Rounds, "Diagnosis and Treatment of Depression" at Grand Rounds, in Dept. of Psychiatry in 5 settings,

1983-84.

Grand Rounds, "Toward the Definition of and Delivery of Mental Health Services: Why Don't Patients Receive

Appropriate Care?" Dept. of Psychiatry, Mt. Sinai, April 1984.

Invited Lecture, "Towards the Definition of and Delivery of Mental Health Services: Why Don't Patients Receive

Appropriate Care?" Dept. of Psychiatry," The University of New Mexico, April 1984.

Grand Rounds, "Toward the Definition of and Delivery of Mental Health Services," Dept. of Psychiatry, College of

Physicians and Surgeons of Columbia University, April 1984.

Grand Rounds, "Psychiatric Hospitalization for the 1980s," Dept. of Psychiatry, New York Medical College,

Valhalla, New York and Metropolitan Hospital, New York City, May 1984.

At the Annual Meeting of the American Psychiatric Association, Los Angeles, May 1984:

Presentation, "Treatment of the Premenstrual Syndromes," as part of a Symposium, "Premenstrual

Syndrome: Current Findings and Future Directions."

Faculty, "Short-Term Psychosocial Inpatient Treatment," as part of a Course, "Short-Term

Psychiatric Treatment."

Leader of Discussion Group, "Delivering State-of-the-Art Multimodality Treatment."

Co-Chair and Presentation, "New Demographic Trends in American Marriage," (with Oliver

Bjorksten, MD and Thomas Stewart, PhD), as part of a Symposium, "New Clinical Concepts in Marital

Therapy."

Chairman and Presentation, "Inpatient Family Intervention: A Controlled Study, Preliminary

Results," (with J. Clarkin, PhD, G. Haas, PhD, J. Spencer, MD, et al), as part of a Symposium,

"Results of Family Treatment: Second Generation Studies."

Grand Rounds, "Is There Any Future for Long-Term Hospitalization?" Silver Hill Foundation, New Canaan, CT,

June 1984.

Grand Rounds, "Which Chronic Patients Most Need Readmission?" Norristown State Hospital, 9/94.

Visiting Lecturer, "Why Don't Patients Receive Appropriate Psychiatric Treatment?" Dept. of Psychiatry, University

of Chicago School of Medicine, September 1984.

Invited Lecturer, "Creativity and Madness," Annual Meeting, Louisiana Psychiatric Society, New Orleans, 9/84.

Invited Lecturer, "Guidelines for Family Therapy," Departments of Psychiatry, Tulane University and Louisiana

State University, October 1984.

Presentation, "The Family Model and the Treatment of Affective Disorders," at Albert Einstein Medical Center,

Northern Division, Philadelphia, October 24, 1984.

Grand Rounds, "Indications and Contraindications," Dept. of Psychiatry, Bronx Lebanon Hospital Center, 11/94.

Departmental Colloquia, "Why Don't Patients Receive Appropriate Psychiatric Treatment?" Dept. of Psychiatry,

University of Pennsylvania, December 1984.

Guest Speaker, "Trends in Marriage & Marital Therapy," South Jersey Psychiatric Society, Cherry Hill, N J, 12/84.

35

35

Co-Chair, ACNP Study Group, "Psychotropic Drug and Psychotherapy Interaction Research," Annual Meeting of

the American College of Neuropsychopharmacology, San Juan, 1984.

Co-Chairman, ACNP Training Session, "Proposed Curriculum for Teaching Psychopharmacology," Annual

Meeting of the American College of Neuropsychopharmacology, San Juan 1984.

Grand Rounds, "Guidelines for Marital and Family Therapy," Detroit Psychiatric Institute and Lafayette Clinic,

Detroit, January 1985.

Continuing Education Workshop, "Family Therapy - Working with Couples," Dept. of Continuing Education,

Harvard Medical School at New York City, January 1985.

Grand Rounds, "Why Don't Patient Receive Appropriate Psychiatric Treatment?" Dept. of Psychiatry, University of

Utah, Salt Lake City, February 1985.

Grand Rounds, "Diagnosis and Treatment of Depression," Coney Island Hospital, New York, February 1985.

Grand Rounds, "Inpatient Family Intervention: A Controlled Study - Preliminary Results," University of California,

San Francisco, February 1985.

Grand Rounds, "New Concepts About Inpatient Family Intervention for Psychiatric Disorders," Peninsula Hospital,

Hillsdale, California and San Mateo Hospital, San Mateo, California, March 1985.

Grand Rounds, "New Concepts in Family Intervention in Chronic Mental Illness," Harlem Valley Psychiatric Center,

Wingdale, New York, March 1985.

Grand Rounds, "Psychiatric Hospitalization for the 1980s: A Controlled Study of Short-Term Versus Long-Term

Hospitalization," Duke University Medical Center, Durham, North Carolina, March 1985.

Invited Faculty, "The `Shrinking' of Inpatient Psychiatry: What To Do About Limited Hospital Stays" and Workshop,

"Family Work on an Inpatient Unit," both as part of course at Harvard Medical School, Dept. of Continuing

Education, Boston, March 1985.

Grand Rounds, "Recent Trends in Marriage and the Family: Effects on Therapy," Tufts-New England Medical

Center, Boston, April 1985.

Grand Rounds, "The `Shrinking' of Hospital Psychiatry," Dept. of Psychiatry and the Behavioral Sciences, USC

School of Medicine, Los Angeles, April 1985.

Grand Rounds, "Inpatient Family Intervention: A Controlled Study," The Medical College of Pennsylvania,

Philadelphia, April 1985.

Grand Rounds, "The Family and Its Role in Diagnosis and Treatment of Depressive Disorder," Georgetown

University School of Medicine, Washington, D.C., April 1985.

Grand Rounds, "Psychoeducation in a Hospital Setting," Silver Hill Hospital, Silver Hill, Connecticut, 5/85.

Grand Rounds, "Guidelines for Marital and Family Therapy: Circa 1985," Dept. of Psychiatry, Stanford Medical

School, Palo Alto, California, May 1985.

At the Annual Meeting of the American Psychiatric Association, Dallas, May 1985:

Workshop, Presentation of "A Model Psychoharmacology Curriculum," (with David S. Janowsky, MD,

Richard I. Shader, MD and Carl Salzman, MD)

36

36

Presentation, "The Family and Antidepressant Noncompliance" (with John Clarkin, PhD and

Gretchen Haas, PhD) as part of a Symposium, "Resistance to Antidepressants: Psychosocial

Factors"

Presentation, "Quality Treatment and Practitioner Competence" as part of a Symposium, " Evaluation of

Knowledge and Practice in Psychiatry - Joint Session with the Association for Academic Psychiatry"

Study Group, "Residents with Marital Distress: The New Epidemic?"

Chairman and Presentation, "Inpatient Family Intervention: A Controlled Study," (with John Clarkin, PhD,

Gretchen Haas, PhD, James H. Spencer, MD, Alfred Lewis, MD and Joanne Newman, M.S.W.) as part

of a symposium "Results of Family Therapy Outcome Studies"

Faculty, "Short Term Psychosocial Inpatient Treatment," as part of a Course, "Short-Term

Psychiatric Treatment"

Workshop, "Family Therapy, Severe Psychiatric Problems and the Psychiatric Hospital:

Critical Issues at the Interface," as part of a series of workshops, "Family Therapy: The Master

Therapists," sponsored by Dept. of Psychiatry, University of Connecticut School of Medicine, 6/85.

Grand Rounds, "Diagnosis and Treatment of Depression," Dept. of Psychiatry, Bowman Gray School of Medicine,

Winston-Salem, North Carolina, August 1985.

Invited Address, "Survival for the Physician and the Family in the 1980s," Capital Medical Society, Tallahassee,

Florida, August 1985.

Grand Rounds, "Indications and Contraindications for Family Therapy," Dept. of Psychiatry, Emory University,

Atlanta, September, 1985.

Invited Presentation, "The Shrinking Of Hospital Psychiatry And What To Do About It," Annual Meeting, Hospital

Corporation of America, Orlando, December 1985.

ACNP Poster Presentation, "Inpatient Family Intervention: The Patient, the Family and Compliance with Drug

Treatment for Affective Disorders," December 1985.

Presentation of paper, "Inpatient Family Intervention: A Controlled Study" at the Annual Meeting of the American

Psychiatric Association, Washington, D.C., May, 1986.

Invited Lecture, "The Family and Recent Developments in Psychiatry," Family Institute of Milan, Italy, 3/86.

Visiting Professor, "`Family Therapy: Indications and Contraindications," Dept. of Psychiatry, School of Medicine

and Surgery, University of Naples, Italy, May, 1986.

Grand Rounds, "The Patient, the Family and Psychiatric Hospitalization," Dept. of Psychiatry, Jefferson Medical

College, Philadelphia, October, 1986.

Grand Rounds, "Psychiatric Hospitalization for the 1980's," Dept. of Psychiatry, Hahnemann University,

Philadelphia, October, 1986.

Grand Rounds, "Treating the Family of the Hospitalized Patient, Is it Worth It?" North Shore University Hospital,

New York, October, 1986.

Grand Rounds, "Combination Therapy: A Study of Inpatient Family Intervention," Westwood Lodge Hospital and

Pembroke Hospital, Boston, October, 1986.

37

37

Grand Rounds, "Receiving Effective Psychiatric Treatment," Albert Einstein Medical Center, PA, 11/86.

Grand Rounds, "Working With The Family - Is It Worth It? A Controlled Clinical Trial of Inpatient Family

Intervention", Dept. of Psychiatry, Cornell University Medical College and Payne Whitney Clinic, The New York

Hospital, November, 1986.

Grand Rounds, "New Developments in the Treatment of Schizophrenia: Combining Drug and Family Therapy,"

Dept. of Psychiatry, Lincoln Hospital, New York, November, 1986.

Grand Rounds, "Psychosocial Interaction in the Treatment of Schizophrenia," Dept. of Psychiatry, Coney Island

Hospital, Brooklyn, November, 1986.

At the Annual Meeting of the American College of Neuropsychopharmacology, Washington, D.C., 1986:

Co-Chair, ACNP Training Session, "Teaching Psychopharmacology in the 1990's"

Chair, Presentation of Paper, "The Teaching of Psychopharmacology in the United States"

ACNP Poster Presentation, "The Patient, the Family, and Compliance with Drug Treatment for

Affective Disorders"

At the Annual Meeting of the American Psychiatric Association, Chicago, Illinois, May, 1987:

Presentation, "Inpatient Family Intervention for Affective Disorders" as part of a Symposium,

"Depression and Families: Recent Advances"

Presentation, "Inpatient Family Intervention for Psychotic Disorders" as part of a Symposium,

"Advances in Family Psychiatry"

Presentation, "Study Design Influences Generalizability of Result" as part of a Symposium, "Long- Term

Treatment Strategies in Schizophrenia"

In Japan, lectures and other activities during sabbatical year, 1987:

1) New Directions in Family Therapy, School of Medicine, Kanazawa University, January.

2) Indications and Contraindications for Family Therapy, Kochi Medical School, Kochi City,Shikoko

3) The Psychoeducational Approach, Psychoanalytic Seminar, Keio University & Hospital

4) Indications and Contraindications for Family Therapy, Tokyo Community Counseling Service

5) The Family on the Move: Family Function and Problems, International School of the

Sacred Heart, Tokyo, April.

6) Diagnosis and Therapy of Depression, Dept. of Psychiatry, Tokai University, April.

7) Psychoeducational Treatment in Psychiatry, Okayama Prefectorial Mental Hospital, April.

8) Indications and Contraindications for Family Therapy, Psychiatric Research Institute of Tokyo

9) Hasagawa Hospital - April-June

a. New Concepts in Treatment of Schizophrenia

b. Psychoeducational Treatment in a Hospital Setting

c. Diagnosis and Therapy of Depression

10) The Changing American Family, Continuing Education Course, Japan NIMH

11) Indications and Contraindications for Family Therapy, Dept. of Psychiatry, School of Medicine,

Fukuoka University

12) Recent Trends in Treatment of Mental Patients, Dept. of Social Administration, Tokyo

Metropolitan Hospital

13) Indications and Contraindications for Family Therapy, Tokyo Family Therapy Association

38

38

14) The Changing American Family, Emerging Trends and Comparisons with the Japanese

Family, U.S. Information Service Seminar, Sapporo, Hokkaido

15) Combination Therapy in Modern Psychiatry, Keio Medical School

16) A Model Psychopharmacology Curriculum, Nihon University, Tokyo

17) The Changing American Family, Emerging Trends and Comparisons with the Japanese

Family, U.S. Information Service Seminar, Tokyo

18) Featured Guest, The Changing American Family, Japanese-American Cultural Program,

NHK - Educational TV

19) The Changing American Family, Emerging Trends and Comparisons with the Japanese

Family, U.S. Information Service Seminar, Nagoya

20) A Study of the Quality of Psychiatric Care - Preliminary Results, Staff Conference, Japan NIMH

Research Conference, "A Controlled Study of Transitional Day Care for Non-Chronically Ill Patients," Dept. of

Psychiatry, Cornell University Medical College and Payne Whitney Clinic, The New York Hospital, 9/87.

Grand Rounds, "Working with the Family of a Hospitalized Patient - Is It Worth It?" Dept. of Psychiatry, Brookdale

Hospital, Brooklyn, New York, September, 1987.

Clinical Conference, Grady Memorial Hospital and Emory Medical School, Atlanta, Georgia, October, 1987.

Invited Lecture, "Recent Advances in Psychiatry: The Family and Family Therapy," Prasat Neurological Hospital,

Bangkok, November, 1987.

Invited Lecture, "Recent Advances in the Treatment of the Psychoses," Dept. of Neurology & Psychiatry, Pra

Mongkutklao Army Hospital, Bangkok, November, 1987.

The Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, 12/87:

Study Group - Drug & Psychosocial Therapy in Schizophrenia and Affective Disorders, Co-Chair with

Nina Schooler, PhD

Presentation of Paper - Inpatient Family Intervention: Final Results for Schizophrenia and

Affective Disorder

Grand Rounds, "New Therapies in Depression: Combining Drugs & Psychotherapy," Pacific Presbyterian Medical

Center, San Francisco, January, 1988.

Guest Consultant, Biological Psychiatry Colloquium, "Clinical Management of a Treatment Resistant Patient with a

Bipolar Compulsive Disorder," Pacific Presbyterian Medical Center, San Francisco, January, 1988.

Grand Rounds, "Inpatient Family Interventions for Psychotic Disorders," South Beach Psychiatric Center, Staten

Island, New York, February, 1988.

Grand Rounds, "Inpatient Family Intervention: A Randomized Clinical Trial," Dept. of Psychiatry, Emory University

School of Medicine, Atlanta, Georgia, February, 1988.

Presentation, "How to Teach Family Therapy and (Even, Sometimes) Succeed," (with Alan Manevitz, MD), Annual

Meeting of the Association for Academic Psychiatry, Free University Section, Tampa, Florida,3/88.

Presentation & Workshop, "The Interface of Psychodynamic Psychotherapy and Psychopharmacology" 10th

Annual Menninger Foundation Winter Conference, Park City, Utah, March, 1988:

39

39

The Annual Meeting of the American Psychiatric Association, Montreal, Canada, May, 1988:

Presentation, "The Family and Schizophrenia" as part of a Symposium, "Psychosocial Treatment of

Schizophrenia" with James Spencer, MD, Gretchen Haas, PhD, John Clarkin, PhD, et al

Presentation, "Inpatient Family Intervention: Follow-up Results" as part of a Symposium, "Psychotherapy:

Process and Outcome" with James Spencer, MD, Gretchen Haas, PhD, John Clarkin, PhD, Alfred

Lewis, MD

Presentation, "Predictors of Early Stabilization in Schizophrenia" as part of a Symposium, "Long-term

Treatment Issues in Schizophrenia" with Nina Schooler, PhD, Sam Keith, MD, Alan Balleck, MD, et al

The Annual Meeting of the Association for Clinical Psychosocial Research, Montreal, Canada, May, 1988:

Presentation, "Family Therapy Manuals: Treatment in Search of a Manual or Manuals in Search of a Treatment"

as part of a Symposium on Psychotherapy Manuals, with John Clarkin, PhD and Gretchen Haas, PhD.

The Annual Meeting of the American Family Therapy Association, Montreal, Canada, June, 1988:

Presentation, "Inpatient Family Intervention: Final Results for Schizophrenia and Affective Disorder"

Plenary Session, "NIMH Update"

The Regional Symposium of the World Psychiatric Association, Washington, D.C., October 1988:

Presentation: "Developing an Effective Treatment Equation"

Presentation: "The Family Model and Schizophrenia"

Participant on Panel: "Mental Health and the News Media," The Fourth Annual Rosalynn Carter Symposium on

Mental health Policy, Atlanta, October 1988.

Keynote Speaker, "National Priorities in Mental Health Research," First Annual Kansas Scientific Symposium,

Kansas City, October 1988.

Grand Rounds, "Family Therapy: Indications and Contraindications," Carrier Clinic, Princeton, NJ, 11/88.

Presentation: "The National Institute of Mental Health Public Academic Liaison Initiative," National Association of

Social Workers 1988 Annual Conference, Philadelphia, Pennsylvania, November 1988.

Presentation: "Fostering Collaborative Research that Impacts the Adminstration of Public Mental Health Programs:

The Federal Perspective." American Public Health Association, Boston, MA, November 1988.

The American College of Neuropharmacology (ACNP) 27th Annual Meeting, San Juan, Puerto Rico, 12/88:

Presentation of paper for the TSS Collaborative Study Group, "Depressive Symptomatology,

Negative Symptoms and Extrapyramidal Symptoms (EPS) in Acute Treatment Response and Short

Term Outcome," as part of a symposium, Acute Treatment Response and Short Term Outcome in

Schizophrenia"

Poster with the IFI Research Group, "Working with the Family to Improve Medication Compliance"

Keynote Remarks, "The NIMH Program for 1989 and its Implications for Training." Annual Meeting of AADRPT,

San Diego, California, January 1989.

40

40

Keynote Address, "NIMH Prospects and Promises," California Coalition for Mental Health, Los Angeles, California,

January 1989.

Presentation of paper, "The Programs of the NIMH and Their Implications for Training," 1989 Annual Meeting of

the Association for Academic Psychiatry, Atlanta, Georgia, March 1989.

Ground Rounds, "Among Doctors, Patients, and Family: Achieving Effective Treatment for Serious Mental Illness,"

Chope Hospital, San Mateo, California, April 1989.

Poster Presentation, "Depressive Symptomatology, Negative Symptoms and Extrapyramidal Symptoms (EMPS)

in Acute Treatment Response and Short Term Outcome," International Congress on Schizophrenia Research,

San Diego, California, April 1989.

At the Annual Meeting of the American Psychiatric Association, San Francisco, California, May 1989:

Workshop, Presentation of "The Family and DSM-IV: A Progress Report from the Group for the

Advancement of Psychiatry" (with LC Wynne MD, L Combrinck-Graham MD, and AL Price MD)

Workshop Chairperson, Presentation of "Public/Academic Liaison: Can It Work?" (with SC Shulz MD. JD

Burke MD, D Jones MSW, and GM Simpson MD)

Presentation, "Inpatient Family Intervention: Process Results" (with JF Clarkin PhD, JH Spencer MD, GL

Haas PhD, and AB Lewis MD) as part of a Paper Session, "Family Therapy Strategies"

Co-author, "Sex Differences in Schizophrenia Outcome," (with GL Haas PhD, JF Clarkin PhD, and

JH Spencer MD) as part of a Paper Session, "Schizophrenia Treatment Outcomes: New Consideration"

Co-author, "Social and Family Factors Predict Early Stabilization," (with NR Schooler PhD, JB Severe MS,

SJ Keith MD. AS Bellack MD, WA Hargreaves PhD, JM Kane MD, and PT Ninan MD) as part of a

Symposium, "Long-term Treatment Issues in Schizophrenia"

Presentation, "State/University Collaboration: The Public-Academic Liaison," National Conference on Mental

Health Statistics, San Diego, California, June 1989

At the Eleventh Annual Meeting of the American Family Therapy Association, Colorado Springs, CO, 6/89

Chair, Interest Group, "Medications, Hospitalization and Family Systems"

Presentation, "The Family and Treatment of Depression"

Presentation, "NIMH Update"

Grand Rounds, "Family Intervention for Affective Disorders," Dept. of Psychiatry, Louisiana State University

Medical Center, New Orleans, October 1989.

Invited Speaker, "The National Plan for Research to Improve Care of the Severely Mentally Ill," at a conference,

"Privatization of Mental Health Care: A National Perspective," Center for Health and Human Resources Policy,

JFK School of Government, Harvard University, Boston, Massachusetts, October 1989.

At the 1989 Institute on Hospital and Community Psychiatry of the American Psychiatric Association, Philadelphia,

October 1989:

Lecture, "Update from the NIMH"

41

41

Workshop, "Follow-up Studies of Hospitalized Psychiatric Patients: Triumphs, Tragedies, and

Surprises" (with Harding, CM)

Symposia, "Family Intervention and Psychiatric Hospitalization" (with Sholevar, GP)

Poster, "Improving Treatments for the Severely Mentally Ill - Implications of the Italian Psychiatric

Reform"

Grand Rounds, "The Effectiveness of Treatment for Major Depressive Disorder One year Later," Jefferson

Medical College, Philadelphia, November 1989.

Workshop, "Fundamentals of Mental Illness Research," National Mental Health Association Scientific Symposium,

Washington, November 1989.

At the 1990 Annual Meeting of the ACNP, Maui, December 1989.

Study Group, "Public/Academic Liaison to Generate Psychpharmacology Research: Can it Work?"

(Co-chair with Schulz S)

Open Session, "New Initiatives of the NIMH - the PAL Initiative"

Grand Rounds, "Working with the Family of the Hospitalized Patient: Is It Worth It Over the Long Run?" Holliswood

Hospital, Queens NY, December 1989.

Presentation of Paper, "A Cross National Followup Study of the Treatment of Major Depressive Disorder," Annual

Meeting Psychiatric Research Society, Park City, Utah, March 1990.

Grand Rounds, "Increasing the Effectiveness of Psychiatric Care: What Happens to Patients and Their Families

After Hospitalization", Dept. of Psychiatry, University of North Carolina, Chapel Hill, April 1990.

At the 1990 Annual Meeting of the American Psychiatric Association, New York, May 1990:

Vestermark Award Session, "Overview of the Model Curriculum and a Follow Up Evaluation of its

Usefulness," as part of the session, "The Teaching and Learning of Psychopharmacology in the 1990's:

How to Jump in a Rapidly Moving Train"

A Workshop, "National Plan Research on Severely Mentally Ill" (with Burke, J)

Presentation, "Cross-National Study of Major Depressive Disorders." as part of Symposium,

"Cultural Aspects of Depression in Asia and America"

Research Colloquia, "Drug and Family Treatment for Major Affective Disorder," Dept. of Psychiatry, University of

Pennsylvania School of Medicine, May 1990.

Brief Presentation, "Making Inpatient Family Intervention Work," American Family Therapy Association,

Philadelphia, June 1990.

Invited Presentation, "Implications of the Italian Reform for the Delivery of Mental Health Services in the U.S. and

Canada," sponsored by British Columbia Mental Health Society, Vancouver, July, 1990

At the 7th Annual Scientific Symposium, National Mental Health Association, "New Findings & Practical

Applications of Mental Health Research" Houston, Texas, 1990:

Workshop, "Fundamentals of Mental Illness Research"

42

42

Workshop, "Increasing the Effectiveness of Psychiatric Treatment."

Professional Symposium Series, "Psychoeducation for Patients and Families: What and How," Portsmouth

Pavilion, Portsmouth, New Hampshire, September, 1991.

Grand Rounds, "Effectiveness for the Patient and Their Families of Psychiatric Care: A Cross-National Study of

the Process of Treatment and Outcome of Major Depressive Disorder," Brookside Hospital, Nashua, New

Hampshire, September, 1991.

Grand Rounds: "The Family and Affective Disorder: A Followup Study." Butler Hospital, Brown University School

of Medicine, Providence, November 1990.

Grand Rounds: "Effectiveness of Inpatient Psychiatric Care: A Two Year Followup Study of Major Affective

Disorder." Manhattan Psychiatric Center, New York, December 1990.

Grand Rounds, "Does Treatment Help? The Process of Hospital Treatment and Outcomes for Major Depressive

Disorder." Dept. of Psychiatry, The New York Hospital-Cornell University Medical College, NY, 1/91.

Presentation, "A Model Curriculum in Psychopharmacology." Annual Meeting of the Association for Academic

Psychiatry, Free University Section, Tampa, Florida, March, 1991.

Grand Rounds, "Increasing Effectiveness of Psychiatric Care: What Happens to Patients and Their Families After

They Leave the Hospital." Dept. of Psychiatry, The New York Hospital-Cornell Medical College-Westchester

Division, NY, March 1991.

Grand Rounds,"The Changing American Couple and Indications for Marital Therapy." State University of New

York Health Science Center at Brooklyn, New York, April, 1991.

At the Annual Meeting of the American Psychiatric Association, New Orleans May 1991:

Presentation: "Family Outcome of Hospitalization for Mood Disorders" with Lorenzo Burti, MD,

Kuninao Minakawa, MD, Michael Sacks, MD, Katsua Maehara, MD

Invited Lecture: "The Integration of Psychopharmacology with Psychosocial Therapies for Treatment of

Psychoses" sponsored by The Bipolar Foundation, Buenos Aires, Argentina, July 1991.

Invited Lecture: "Psychoeducation as the Tool to Integrate Psychopharmacology with Psychosocial Therapies for

Schizophrenia and Bipolar Disorder." sponsored by The Uruguayian Psychiatric Society, Montevideo, Uruguay,

July 1991.

Invited Lecture: "Effectiveness in Psychiatric Care: A Followup Study of Major Affective Disorder." Dept. of

Psychiatry, LSU, New Orleans, October 1991.

Clinical Research Award Address: "Effectiveness in Psychiatric Care: II. Outcome for the Family After Hospital

Treatment for Major Affective Disorder." Annual Meeting of the American Academy of Clinical Psychiatrists, New

Orleans, October 1991.

At the Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December 1991:

Study Group, "Maximizing the Effectiveness of Medication for Schizophrenia and Affective

Disorder," Study Group organizer and Co-chair as well as Presenter (with four others)

Presentation, "Effectiveness of Psychiatric Care, A Followup Study of Psychopharmacologic

Practices in Treatment of Major Affective Disorder." As part of a Symposium on Transcultural

Psychopharmacology organized by T. Ital and N. Sartorius

43

43

Poster, "Increasing the Effectiveness of Psychiatric Care: Achieving Effective Medication Management"

(with three others)

Grand Rounds, "The Changing American Couple and Indications for Marital Therapy." Coney Island

Hospital, Brooklyn, New York, January, 1992

At the Annual Meeting of the American Psychiatric Association, Washington, D.C., May 1992:

Debate: Resolved: For Most Psychiatric Inpatients, a Ten Day Hospitalization is as Effective as a Longer

Stay (with M. Herz, MD)

Paper: Increasing the Effectiveness of Treatment for Mood Disorder, as part of a symposium, The Family

and Mood Disorder.

New Research Poster: "Psychoeducation For Mood Disorder" with Lorenzo Burti, MD, Keigo

Okonogi, MD and Michael Sacks, MD.

Poster: "Achieving Effective Medication Management" with Lorenzo Burti, MD, Koji Suzuki, MD and Michael

Sacks, MD, NCDEU Annual Meeting, Boca Raton, Florida, June 1992.

International Seminar: "Revamping of the Uruguayan Mental Health System: New Patterns of Care, Methods of

Diagnosis and Treatment for Severe Mental Disorders" sponsored by the Uruguayan Psychiatric Association,

World Association for Psychosocial Rehabilitation and the Republican National Bank, Director and Lecturer,

Uruguay, June 1992 with John P. Docherty, MD.

Grand Rounds: "Alternative Treatments of Bipolar Disorder." Bronx State Psychiatric Center. NY9/92.

Grand Rounds: "Effectiveness in Psychiatric Care: A Follow-up Study of Hospitalized Patients with Major Affective

Disorder." St. Vincent's Hospital and Medical Center. New York. September, 1992.

Grand Rounds, "Alternative Treatments of Bipolar Disorder." Bronx State Psychiatric Center, NY,9/92.

Invited Plenary Lectures: At the Fall Meeting, Louisiana Psychiatric Association, Destin, Florida, 1992:

a) "Theoretical Background and Literature Underlying Psychopharmacotherapy and

Marital/Family Therapy Combinations"

b) "The New Algorithms for Combining Marital/Family Therapy with Drug and Other Psychotherapies"

Invited Lecture, "The Role of Psychotherapy in Combination with Pharmacotherapy," as part of a symposium,

"Bipolar Disorder: Current Progress and Future Directions in Diagnosis and Management," sponsored by Stanford

University School of Medicine, San Francisco, October, 1992.

Workshop, "The Millennium Has Arrived: Suggestions for a New Model of (and Research Questions about)

Hospital Treatment of Psychiatric Disorders," Institute on H&CP, Toronto, October, 1992.

Grand Rounds, "Combining Medication and Psychosocial Strategies for the Treatment of the Major Psychoses."

Stanford University Medical Center, Stanford, CA, November, 1992.

Grand Rounds, "Effectiveness in Psychiatric Care: What Happens to the Patient and Family After Hospitalization."

Creedmoor Psychiatric Center, New York, December, 1992.

44

44

At the Annual Meeting of the American College of Neuropharmacology (ACNP), Puerto Rico, December 1992:

Paper, Treatment Strategies in Schizophrenia, (with 12 co-authors)

Invited Lecture: "Combining Treatments to Improve Outcomes: A Follow up Study of Major Affective

Disorders in Italy, Japan and the United States." Bronx District Branch of the American Psychiatric

Association, New York, March, 1993.

At the Annual Meeting of the American Psychiatric Association, San Francisco, May, 1993:

Invited Speaker for the Annual Review of Psychiatry Series, the Combined Treatments Symposium,

Combining Medications with Family Psychotherapy (with Scott Goldsmith and John Clarkin)

Workshop, Medication and the Italian Reform (with L. Mosher, G. Palermo and A. Bartolomeis)

Lecture: "Increasing Effectiveness of Psychiatric Inpatient Care." Medical Staff, Dept. of Psychiatry, Stanford

University Hospital, September, 1993.

Grand Rounds, "Effectiveness in Psychiatric Care." Dept. of Psychiatry, Bronx-Lebanon Hospital Center, Bronx,

NY, November 1993.

At the Annual Meeting of the American College of Neuropharmacology (ACNP), Hawaii, December 1993: Paper, Promising New Medications for Schizophrenia not Available in the U.S.A., (with five co-authors) as part of the European College of Neuropsychopharmacology panel, Are You Missing Anything? Recent Psychotropics Available in Europe, But Not in U.S.A. (Chair, Stuart Montgomery) Poster, Promising Psychopharmacologic Medications not Available in the U.S.A. (with five co-authors)

Lecture: "Medication Combined With Couples Treatment" as part of a symposium, "Clinical Pharmacology: An

Update", Stanford University School of Medicine, January, 1994.

Grand Rounds: “The Role of the Psychiatric Hospital in the 1990’s,” Langley Porter Psychiatric Institute, UCSF,

San Francisco, March 1994.

Grand Rounds: “New Strategies for the Treatment of Acute and Chronic Schizophrenic.” California Medical

Facility, Vacaville, CA. April 1994.

Grand Rounds: “Atypical Antipsychotic Medications,” Sacred Heart General Hospital, Eugene OR, April 1994

Invited Presentation: “A Cross Cultural Study of Treatment of Mood Disorders in Italy, Japan and the United

States,” The Northern California Psychiatric Society 1994 Annual Meeting, Olympic Valley, CA, April, 1994.

Lecture: “New Strategies for Treatment of Acute and Chronic Schizophrenia” as part of a symposium, New

Approaches to Treating Schizophrenia. Stanford University School of Medicine, May 1994.

Paper: Psychiatric Aspects of Basketball Annual Meeting, International Society of Sports Psychiatry, Philadelphia,

May 1994. Poster: Efficacious and Safe Psychotropics Not Available in the US., 1994 Annual Meeting, Society of Biological Psychiatry, Philadelphia, May 1994. Training Seminar: The Legal - Psychiatric Interface, for San Francisco, Santa Clara & San Mateo judges and other legal mental health professionals, San Jose, CA, August, 1994.

45

45

Keynote Address, "Combining Medication with Psychosocial and Rehabilitation Strategies in the '90s": sponsored by

the Department of Psychiatry, University of Saskatchewan and the Department of Psychiatry, University of Alberta

Hospitals, presented at Edmonton, Saskatchewan, and at Kingston,Canada, October, 1994.

Grand Rounds, "Combining Medications and Psychotherapy in the 1990's: Researching Clinical Issues". California

Pacific Medical Center, San Francisco, October, 1994.

Grand Rounds, "Changing Models of Psychiatric Care: Psychiatric Hospitalization for the 90's." Chope Hospital &

San Mateo Health Services Agency, San Mateo, CA, November, 1994.

Poster: "Current European Clinical Trials of Anti-Dementia Drugs," (with Shwartz GE, Montgomery S, Klein F) at

the 1994 Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico,

December, 1994.

Grand Rounds, "Combining Psychotherapy and Drugs in the 1990's." Department of Psychiatry, University of

Arizona Health Sciences Center, Tucson, January, 1995.

Lecture: "Combining Psychotherapy & Pharmacotherapy" as part of the 1995 Annual Meeting of the American

College of Psychiatrists, Acapulco, Mexico, February, 1995.

Grand Rounds, "Diagnosis and Treatment of Psychotic Disorders Related to Parturition" Department of Ob/Gyn,

Stanford University School of Medicine, March, 1995.

At the Biannual International Congress on Schizophrenia Research (ICSR), Warm Springs, VA, May, 1995

Poster: Lithium Augmentation Fails to Reduce Symptoms in Poorly Responsive Schizophrenic

Outpatients, (withSchultz SC, TSS Collaborative Study Group). Poster: Promising Psychopharmacologic Medications Not Available in the USA, Glick, ID, (with Lecrubier Y, Montgomery S, Vinar O, Klein DF). Clinical Update: "The Forces Forming Character," at the 1995 Annual Meeting of the Northern California Psychiatric Society,Pacific Grove, CA, April,1995.

Keynote: "Combining Family Therapy with Medication for the Treatment of Axis I Disorders." as part of seminar, Effective Approaches: Working With Children, Adolescents and Their Families. Tender Lion Family Program, Family Service Agency of San Francisco, April 1995. Grand Rounds: "New Strategies for Treating Schizophrenia," Eden Hospital, Castro Valley, CA, May, 1995.

Poster: "New Psychopharmacologic Strategies for Treatment," (with Braff D, Janowsky D) at the 1995 Annual Meeting of the Society for Biological Psychiatry, Miami, FL, May, 1995. Grand Rounds: "The Effectiveness of Family Therapy for Inpatient Psychiatric Patients,” Department of Psychiatry, School of Medicine, UC Davis, and Sacramento County Mental Health, Sacramento, November, 1995. Grand Rounds: "Psychiatric Hospitalization for the 90's," Napa State Hospital, Napa, CA, December,1995. At the Annual Meeting of the American College of Neuropsychopharmacology (ACNP), Puerto Rico, December 1995. Mentor: Travel Awardee. Poster: New Treatment Strategies, (with Braff D, Janowsky D). Poster: Treatment Outcomes of First Episode & Chronic Multiepisode Schizophrenia, (with Lieberman J, et al). Study Group: A Psychopharmacologic Jam Session: A Dialogue on Tricks of the Trade, (with Janowsky D, Klein D, Schatzberg A)

46

46

Lecture: "Family Therapies: Efficacy, Indications and Therapy Outcomes." Annual Meeting of the American Psychopathological Association, New York, March, 1996. Lecture: "Pharmacologic Treatment of Schizophrenia,” at the 1st Stanford Review of Psychopharmacology Course, San Francisco, March, 1996. Grand Rounds: “A Model Curriculum in Psychopharmcology for the 21st Century,” San Mateo County General Hospital, San Mateo, March, 1996. Grand Rounds: “Sertindole and New Antipsychotic Therapies for Schizophrenia,” Atascadero State Hospital, Atascadero, CA, April, 1996. Grand Rounds: “New Treatments and New Pharmacologic Strategies for Schizophrenia,” Sutter Center for Psychiatry, Sacramento, CA, April, 1996. Lecture: “Advancing the Treatment of Mania.” Departments of Psychiatry, University of California, Irvine and University of Southern California, Los Angeles, CA, June, 1996. At the Annual Meeting of the American Family Therapy Academy, San Francisco, June 1996. Poster: “Inpatient Family Intervention: Final Results from a Controlled, Random-Assignment Study,” (with three others). Roundtable: “The Family Model and Psychiatric Illness.” Grand Rounds: “Combing Medication with Family Intervention for Axis I Disorders,” Hackensack Hospital Medical Center, Hackensack, NJ, September, 1996. International Congress: Schizophrenia: New Frontiers, Association for Research on Schizophrenia, Milan, October, 1996. Keynote: “Family Associations and Family Therapy: From Conflict to Collaboration.” Workshop: “Psychoeducational Treatment of Schizophrenia: The Inpatient Family Intervention Study Experience” Grand Rounds: “Treatment Strategies in Schizophrenia: Final Results,” Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences, Stanford, CA, November, 1996. Grand Rounds: “New Drugs and New Strategies in Schizophrenia,” Menlo Park Veterans Administration Hospital and Palo Alto Veterans Administration Hospital, Menlo Park and Palo Alto, CA, November, 1996. Grand Rounds: “Combining Medication with Psychotherapeutic Intervention, “ Dept of Psychiatry, University of Miami School of Medicine, Miami, December, 1996. Grand Rounds: “Atypical Antipsychotics & New Treatments/New Strategies for Schizophrenia” • Kaiser Hospital, San Francisco, CA, November, 1996 • Central Missouri Psychiatric Society, St. Louis, MO, November, 1996 • Boone County Medical Society, MO, November, 1996 • Fulton State Hospital, Fulton, MO, November, 1996. • Coutesville V-A Medical Center, Coutesville, PA, December, 1996 • Institute of Pennsylvania, Philadelphia, PA, December, 1996 • Arizona Alliance for the Mentally Ill, Phoenix, AZ, January, 1997 • Good Samaritan Regional Medical Center, Phoenix, AZ, January, 1997 • Porter Hospital, Denver, CO, January, 1997 • University of Colorado Health Sciences Center, Denver, CO, January, 1997 • First Hospital, Vallejo, CA, February, 1997 • Mercy Memorial Hospital, Ardmore, OK, March, 1997 • St Mary’s Hospital, Colorado West Mental Health Meeting, Grand Junction, CO, April, 1997 • Lakeview Veterans Administration Hospital, Chicago, IL, June, 1997 • California Psychiatric Society South Coast Chapter, Santa Cruz, CA, July, 1997 • County of Santa Cruz Community Mental Health Services, Santa Cruz, CA, July, 1997 • Fulton State Hospital, Fulton, MO, August, 1997 • Department of Psychiatry, School of Medicine, University of Missouri, Columbia, MO, August, 1997

47

47

• Flower Hospital, Toledo, OH, September, 1997. • International Health Care, Salt Lake City, UT, September, 1997. • Napa State Hospital, Napa, CA , 1997. • Sacred Heart Medical Center, Spokane, WA, October, 1997. • John George Psychiatric Pavilion, San Leandro, CA, November, 1997. • Tampa General Hospital, Tampa, FL, February, 1998. • Florida Hospital, Orlando, FL, February, 1998. • Peninsula Hospital, Burlingame, CA, January, 1999. At the Annual Meeting of the American College of Neuropsychopharmacology (ACNP), Puerto Rico, December, 1996. • Study Group: “A Psychopharmacologic Jam Session:Tricks of the Trade,” moderator and participant. • Poster: “New Psychotropic Drugs for Axis I Disorders: Recently Arrived, In Development, and Never Arrived” (with Belanoff J, Golden W). Grand Rounds: “Inpatient Family Intervention: A Controlled Study,” National University of Taiwan, Taipai, Taiwan, December, 1996. Grand Rounds: “Combining Medication with Family Intervention for Axis I Disorders,” Texas Tech Health Sciences Center, Amarillo, TX, January , 1997. Medical Students’ Forum: “Working With Families of Seriously Ill Patients,” Texas Tech Health Sciences Center, Amarillo, TX, January, 1997. Grand Rounds: “Combined Therapy for Treatment of Axis I Disorders,” First Hospital Vallejo, Vallejo, CA, February, 1997. Research Seminar: “Treatment Strategies in Schizophrenia: Final Results,” Department of Psychiatry, College of Medicine, University of Iowa, Iowa City, IA, March, 1997. Grand Rounds: “Combining Medicine in Psychosocial Intervention,” Department of Psychiatry, College of Medicine, University of Iowa, Iowa City, IA, March, 1997. Keynote: “New Developments in Antipsychotics,” Western Colorado Psychiatric Meeting, Colorado Springs, CO, April, 1997. International Congress on Schizophrenia Research, Colorado Springs, CO, April 1997. Poster: New Psychotropic Drugs for Schizophrenia (with Belanoff J). Grand Rounds: “Diagnosis and Treatment of Schizophrenia,” St. Vincents Hospital, New York, NY, April 1997. Invited Seminar: “New Treatments for Agitation and Aggression in Axis I Disorders,” University of Medicine and Dentistry of New Jersey, Piscataway, NJ, April, 1997. Lecture: “Current Concepts in the Treatment of Schizophrenia,” Conference: Understanding and Treating Schizophrenia: Progressing into the Next Century, Ann Arbor, MI, April, 1997. At the Annual Meeting of the American Psychiatric Association, San Diego, CA, May, 1997: Paper: “New Strategies and New Treatments for Schizophrenia,” (with Belanoff J and DeBattista C). Paper: “The Professional Athlete as Role Model.” Poster: “The Teaching of Psychopharmacology in the 1990’s,” (with Klein D, Doraiswamy M, Lydiard B). NCDEU Annual Meeting, Boca Raton, FL, June, 1997. Lecture: “Combining New Antipsychotics with Psychosocial Intervention in the 1990’s,” St. Lawrence Hospital, E. Lansing, MI, September, 1997. Lecture: “Combining New Antipsychotics with Psychosocial Intervention in the 1990’s,” as part of the program, Contemporary Issues in Psychiatry. Huran Valley Center, Yipsilanti, MI, September, 1997.

48

48

Lecture: “New Treatment Approaches for Psychosis in the Elderly,” McComb Hospital, Detroit, September, 1997. Grand Rounds: “New Treatments for Schizophrenia,” Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, October, 1997. Grand Rounds: “New Treatments for Schizophrenia,”Department of Psychiatry, School of Medicine, Indiana University, Indianapolis, IN, November, 1997. At the 36th Annual Meeting of the American College of Neuropsychopharmacology (ACNP), Waikoloa, HI, December, 1997. Poster: “The Teaching of Psychopharmacology in the 1990’s,” (with ASCP Committee)). Poster: “Extrapyramidal Symptom Profile of Sertindole,” (with L. Ramirez) Continuing Education Update on Schizophrenia, for Neuroscience Regional Research Managers, Eli Lilly Co., at Stanford University School of Medicine, February, 1998. Expert Breakout Session (Schizophrenia). Second Stanford Psychopharmacology Review Course. Stanford, CA, March, 1998. Lecture: “New Treatments and New Strategies for Schizophrenia: New Data,” West Coast College of Biological Psychiatry, Palo Alto, California, 1998. Lecture: “Progress in Psychoses: Improving Treatment and Evaluation, Enhancing Cognition,” Continuing Medical Education Seminar, Los Angeles, April, 1998. Grand Rounds: “Combining Medication with Psychotherapy,” Weber County Mental Health Center, Ogden, Utah, April, 1998. Grand Rounds: “New Treatments and New Strategies for Schizophrenia,” University of California at Irvine, Irvine, California, April 1998. Grand Rounds: “New Treatments and New Strategies for Schizophrenia,” Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, May 1998. Grand Rounds: “Combining Medication and Psychotherapy for Psychiatric Disorder,” North Shore University Hospital, Great Neck, New York, May 1998. Grand Rounds: “Combining Medication with Psychotherapy,” Department of Psychiatry, Wright State University School of Medicine, Dayton, Ohio, May, 1998. Grand Rounds: “The Patient, the Family and Medication,” Palo Alto and Menlo Park Veterans Administration, California, June , 1998. At the Annual Meeting of the American Psychiatric Association, Toronto, May, 1998: Industry Symposium: “ New Atypical Antipsychotics: Data versus Clinical Experience,” Chair and lecturer: Lecture 1: “History of Somatic Therapy for Schizophrenia” Lecture 2: “Combining Medication with New Antipsychotics” Grand Rounds: “An Overlooked Serotonin Dopamine Blocker; Loxapine Revisited,” Atascadero Forensic Center, Atascadero, California, September, 1998. Grand Rounds: “New Atypical Antipsychotics,” Department of Psychiatry, Louisiana State University, New Orleans, October, 1998. Lecture: “Schizophrenia: Receptor Profiles & Efficacy,” at the Continuing Education Seminar, Psychopharmacology 1998 Clinical and Research Update, sponsored by Department of Psychiatry, Stanford University and West Coast College of Biological Psychiatry, San Francisco, California, October , 1998.

49

49

Invited Lecturer: “Clinical Efficacy of Antipsychotics,” at the World Psychiatric Association and the Mexican Psychiatric Association, Guadalajara, Jalisco, Mexico, October, 1998. Invited Lecturer: “Combining Medication Therapy with Family Interventions,” Bipolar Disorder Mini fellowship, Stanford University School of Medicine, Palo Alto, California, November,1998 Grand Rounds: “Combining Medication with New Antipsychotics,” Herrick Hospital, Berkeley, California, November, 1998. Invited Lecturer: “A Model Curriculum in Psychopharmacology,” Payne Whitney Clinic and Cornell University Medical College, New York, December, 1998. At the Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December, 1998: Study Group: A Psychopharmacological Jam Session: A Dialogue on Psychosis, (Moderator and Participant) Poster: “New Psychotropic Drugs for Axis I Disorders; Recently Arrived, in Development and Never Arrived,” (with JK Belanoff and JS Ballon). Poster: “The Teaching of Psychopharmacology in the 1990’s: The First Year Experience with the Model Curriculum,” (with PM Doraiswamy, J Halper, DS Janowsky, DF Klein, RB Lydiard, J Osterheld, DW Preven, P Ross, NG Ward and S Zisook). Grand Rounds: “Combining Medication and Psychotherapy for Axis I Disorders,” Dept Psychiatry, College of Physicians and Surgeons and New York State Psychiatric Institute, New York, December, 1998. Grand Rounds: “Combining Medications with Psychosocial Intervention for Axis I Disorders,” Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texas, January,1999. Grand Rounds: “Combining Medications with Psychosocial Intervention for Axis I Disorders,” Department of Psychiatry, University of Texas at Houston, March, 1999. Symposium: “ Teaching Biological Psychiatry to Residents, West Coast College of Biological Psychiatry, Tucson, April, 1999. At the Biannual International Congress on Schizophrenia Research, Santa Fe, April, 1999: Poster: “The Efficacy Spectrum for New Antipsychotics in Clinical Practice with S Marder, P Vasudevan. Poster: “Comparisons of the Effects of the Newer Atypical Antipsychotics in the Treatment of Schizophrenia,” with J Davis. Grand Rounds: “Combining Drugs and Ps;ychotherapy for Axis I Disorders.” Department of Psychiatry, University of Mississippi Medical Center, Jackson, May, 1999. At the Annual Meeting of the American Psychiatric Association, Washington DC, May, 1999: Paper Presentaton: “A Model Psychopharmacology Curriculum (with DF Klein and B Lydiard, et al) Paper Presentation: “Keeping the Athlete Functioning,” (with J Horsfall). Invited Lectures: “The New Atypical Antipsychotics - Efficacy and Outcomes,” delivered in May, 1999 at

Departments of Psychiatry in Japan at: • St Marianna University, Tokyo • Hiroshima University, Hiroshima • Kyorin University, Tokyo • Fukushima Medical University (joint sponsorship with the Fukushima Medical Society), Fukushima Invited Lecture: “Psychopharmacology in Psychiatry.” Department of Psychiatry, University Hospital Utrecht, The

Netherlands, August 1999. Grand Rounds: “New Treatments for Psychoses.” The Netherlands, August, 1999. •Vincent van Gogh Hospital, Venray • Delta Hospital, Portugal Workshop: Annual Meeting of the Association for Academic Psychiatry, New Orleans, October, 1999.

50

50

• A Follow up Evaluation of a Model Curriculum in Psychopharmacology, 1999 Workshops: Northwest Medical Health Institute and Oregon Psychiatric Association, Gleneden Beach, Oregon,

November, 1999. • New Treatments for Psychosis in the Year 2000 • Combining Medication with Psychotherapy for Axis I Disorders Grand Rounds: “Combining Medication with Psychotherapy for Axis I Disorders.” Santa Barbara County CMHC,

Santa Barbara, November, 1999. Grand Rounds: “New Short and Long-term Strategies for Schizophrenia, Bipolar Disorder and Depressive

Disorder.” Department of Medicine, Stanford University School of Medicine, December, 1999. Grand Rounds: “Teaching Psychopharmacology in the New Millennium.” Department of Psychiatry, University of

Hawaii at Manoa, December, 1999. Study Group Presentation: “Clozapine Treatment Resistance: What Does it Mean? New Methodological Issues in

the Study of Treatment Refractory Schizophrenia,” at the Annual Meeting of the ACNP, Acapulco, Mexico, December, 1999.

Invited Lecture: “New Treatments and New Strategies for Psychosis for the Millennium,” 2000 Annual Meeting of

the Philippine Psychiatric Association, IIilo, Philippines, January, 2000. Grand Rounds: “Combining Medical and Psychosocial Interventions for Schizophrenia.” Grand Rounds

Presentation at Nihon University and Keio University, Tokyo, Japan, February, 2000. Workshop: Organizer and Moderator, “Introduction to Neuropsychopharmacology: Pathophysiology to Clinical

Practice.” A Workshop for the Neurobiology Unit, Roche Bioscience. Palo Alto, CA, February, 2000. Lectures: • Overview of New Medication Strategies for Axis I Disorders • Schizophrenia • Clinical Trials Design (with Alan Schatzberg) Invited Lecture: “Long Term Maintenance: Risperidol versus Haldol.” In the symposium, “Psychosis: New

Perspectives and Strategies,” Monte Carlo, March, 2000. Korea: April, 2000

• Grand Rounds: “Indications for New Antipsychotics,” Seoul National University, Seoul.

• Invited Lecture: “New Treatments for Bipolar Disorders,” Annual Meeting, Korean Psychopharmacology

Association.

• “New Antipsychotics for Bipolar Disorder,” Samsung Hospital, Seoul.

• Regional Symposium, Kyong-Ju, “New Antipsychotics for Bipolar Disorder.”

• Regional Symposium, Kwang-Ju, “New Antipsychotics for Bipolar Disorder.”

At the 2000 Annual Meeting of the American Psychiatric Association, Chicago, May, 2000. • Industry-supported Symposium: New Antipsychotics: From Practice to Theory. - Co-chair and Paper, “The Efficacy Spectrum for Atypicals in Clinical Practice.” • Symposium: Psychopharmacological Approaches to the Athletic and Exercise Population. - Paper, “Diagnosis and Psychiatric Treatment of Athletes.” • Media Session: - Cultural Identity on the Tex Mex Border: Impact on Relationships Past and Present, discussion of movie, Lone Star, Chair and Presenter Co-Chair, Forum, “The Future of Psychopharmacology: Generativity and Mentoring” at the NCDEU Annual

Meeting, Boca Raton, May, 2000. Grand Rounds: “Combining Medication with Psychotherapeutic Intervention for Axis I Disorders.” Department of

Psychiatry, University of California at San Diego, June, 2000. Grand Rounds: “Atypical Antipsychotics.” Alameda Center for Behavioral Healthcare, June, 2000.

51

51

Sabbatical, New Zealand and Australia, July-August, 2000

New Zealand

Grand Rounds, “New Treatments for Psychosis,” Dept Psychiatry, School of Medicine, Otago University,

Dunedin, July, 2000.

Australia (August, 2000)

All “grand rounds” presentations or as “invited lecturer” for community mental health practitioners and

students on 1) atypical antipsychotics, 2) combining medication with psychotherapy and/or 3) the teaching

and learning of pharmacotherapy.

Brisbane

• Royal Brisbane Hospital

• Princess Alexandra Hospital

• Prince Charles Hospital

• Ipswich Hospital and Wolsten Park Hospital

Sydney

• Royal North Shore Hospital

• Macquarie Hospital

• Hornsby Hospital and Manley Hospital

• Cumberland Hospital

• Nepean Hospital

• St. Vincents Hospital

Melbourne

• Royal Melbourne Hospital

• St. Vincents Hospital

• Alford Hospital

• Teleconference: Hallarat, Bendigo, Hobart, Warrnambool and Trarigan Hospitals

• EPPIC Mental Health SKY Unit

• Round Table with Professors of Psychiatry, Victoria

• Plenary Lecture: New Trends in Treating Psychosis regional symposium

Adelaide

• Royal Adelaide Hospital, Glenside Campus

• Lecture, Southern Australian Psychiatrists

Perth

• Graylands Hospital

• Lectures, Psychiatrists both Southern and Northern regions

• Queen Elizabeth Hospital

Grand Rounds: “New Drugs for Brain Disorders.” Department of Pharmacology and Toxicology, College of

Pharmacy, University of Texas, Austin, September 2000. Grand Rounds: “Combining Medication and Psychotherapy.” Department of Psychiatry, University of Texas, San

Antonio, September 2000. Invited Speaker: “New Drugs for the Treatment of Psychoses.” Central California Psychiatric Society, Fresno,

September 2000.

Workshop: “The Nuts and Bolts of Psychiatric Course Planning in the New Millennium.” 2000 Annual Meeting of

the Association of Academic Psychiatry, Vancouver, October, 2000 (with Rona Hu).

Grand Rounds: “The New Atypical Antipsychotics.” Western State Psychiatric Hospital, Seattle, November, 2000.

Invited Lecturers: US Psychiatric and Mental Health Congress, San Diego, November 2000

• “Combining Medication and Psychotherapeutic Intervention”

• “Diagnosis and Psychiatric Treatment of the Elite Athlete”

52

52

Grand Rounds: “Cutting Edge Inpatient Pharmacotherapy.” San Mateo Community Mental Health Service. San

Mateo, November 2000.

Postgraduate Education Seminar, for Lilly Pharmaceutical Co. (Japan). “Treatment of Psychosis in the New

Millennium,” Dec. 2000.

At the 2000 Annual Meeting of the ACNP, Puerto Rico, December, 2000

• Study Group: Comparing Antipsychotics: What Do We Really Know? Chair and Presenter; (with Rajiv

Tandon, Moderator).

• Poster, A Model Psychopharmacology Curriculum (with the ASCP Committee)

• Poster, The Efficacy and Extrapyramidal Side Effects of the Atypical Antipsychotics (with J. Davis).

Grand Rounds: “New Antipsychotics – Controversies and Questions.” Palo Alto Veterans Administration, Palo Alto, January 2001.

Invited Lecture: “Psychosis and Atypical Antipsychotics,” at the conference “Psychopharmacology in the Year

2001,” sponsored by the American Society of Clinical Psychopharmacology, Maui, February 2001.

Grand Rounds: “New Treatments for Psychosis.” Maui Community Mental Health Center, Maui, February 2001.

Preceptor: “Update on Schizophrenia.” Pfizer Preceptorship, Stanford, CA, February 2001.

Invited Lectures: Japan, March 2001

• “Combining Medication with Psychosocial Intervention for Treatment of Schizophrenia,” at 1) Department

of Psychiatry for School of Medicine, Hiroshima University, 2) at Kita-Kyusyu University, Kyushu, and 3) at

the National Center of Neurology and Psychiatry (NCNP), Tokyo.

• “Atypical Antipsychotics,” for the Department of Psychiatry, School of Medicine, Chiba University, Chiba.

Grand Rounds: “Long-term Treatment of Schizophrenia in the Community.” Santa Maria County Mental Health

Center, Santa Maria, CA, April 2001.

Lecture: “Treatment of Geriatric Psychosis.” St Johns Medical Center, Oxnard, CA, April 2001.

Grand Rounds: “Atypical Antipsychotics.” Santa Barbara College Hospital, Santa Barbara, CA, April 2001.

Invited Lecture: “Diagnosis and Management of Treatment-Resistant Schizophrenia,” at the symposium,

“Psychiatric Care in Community Residential Setting,” sponsored by the Los Angeles County of Mental Health and the Southern California Psychiatric Society, Los Angeles, CA, April 2001.

At the 2001 Annual Meeting of the American Psychiatric Association, New Orleans, May, 2001.

• Chair, Industry Symposium, A New Era for Managing Psychosis: Rebuilding Lives for Patients and

Families.

Paper, “Consumer Organizations May Improve Medication Compliance.”

• Poster, “The Efficacy and Extrapyramidal Side Effects of the Atypical Antipsychotics,” with Davis, J.

• Poster, “Ziprasidone’s Benefits Versus Olanzapine on Weight and Insulin Resistance.”

• Presentation, A Model Curriculum in Psychopharmacology, at the workshop, “Teaching

Psychopharmacology to Residents Using Evidence-based Algorithms.”

NCDEU 2001 Annual Meeting, Phoenix, May, 2001

• Poster, “The Efficacy and Extrapyramidal Side Effects of the Atypical Antipsychotics.”

• Co-Chair, Workshop, “Mentoring Throughout the Professional Life Cycle: Challenges and Lessons”

(with A. Gelenberg)

7th World Congress of Biological Psychiatry, Berlin, Germany, July 2001

• Poster, “Ziprasidone vs Olanzapine: Weight, Lipids, Insulin.”

53

53

Grand Rounds: “New Antipsychotics: Ziprasidone.” Kaiser, Santa Teresa, San Jose, August 2001.

CME Lecture: “Schizophrenia: New Treatment Dimensions,” at the program, “Psychopharmacology Clinical and

Research Update,” sponsored by the West Coast College of Biological Psychiatry, San Francisco, CA,

October 2001.

Grand Rounds: “New Antipsychotics: Current Controversies.” Menlo Park Veteran’s Administration Hospital,

Menlo Park, December, 2001.

At the 2001 Annual Meeting of the American College of Neuropsychopharmacology, Hawaii, December 2001.

• Chair, Special session, “Teaching Neuropsychopharmacology,” and presentation, “The Teaching of

Psychopharmaclogy: Who Does It? With What Materials?)

• Poster, “Improving the Teaching of Psychopharmacology: Circa 2001,” (with D Janowsky and S Zisook).

• Poster, “The Efficacy of Atypical Antipsychotics Compared to Typical Antipsychotics: A Meta-Analysis

Revisited,” (with N Chen and J Davis).

Lectures: “Current Controversies Around the New Atypical Antipsychotics,” at the Nevada Adult Mental Health

Center, and the Psychiatry Dept, Nevada Dept of Corrections, Reno, Nevada, Dec. 2001.

Grand Rounds: “Advancements in the Management of Schizophrenia.” Spokane Community Mental Health

Center, January, 2002.

Grand Rounds: “Schizophrenia: The New Atypical Antipsychotics.” Dept of Psychiatry, Oregon Health Sciences

University, Portland, Oregon, January, 2002.

Grand Rounds: “New Data and New Indications for the Atypical Antipsychotics in Both Psychotic and Non-

psychotic Disorders.” Department of Psychiatry and Behavioral Sciences, Stanford University School of

Medicine, Stanford, CA, March, 2002.

Invited Lecture: “The Use of New Antipsychotic Agents to Treat Bipolar Disorder,” as part of a CME course on

treating BIpolar Disorder. Department of Psychiatry, UC Davis, Sacramento, CA, March, 2002.

Grand Rounds: “Clinical Management of Psychosis: The Short- and the Long-term.” UCLA Neuropsychiatric

Institute, Los Angeles, CA, April, 2002.

Grand Rounds: “Fiscal Pharmacology of the Atypical Antipsychotics.” Napa State Hospital, Napa CA, April,

2002.

CME Lecture: “Stabilizing the Dopamine-Serotonin System: A New Era in the Treatment of Psychosis.” San

Diego, CA June, 2002.

Grand Rounds: “The Efficacy of Atypical Antipsychotics: A Meta-analysis Revisited.” Manhattan State

Hospital, New York, New York, June 2002.

Sabbatical, Japan, July 2002

Plenary Lectures: “The New Atypicals: New Data and Controversies” at the symposium “Challenges and

Opportunities in the Management of Schizophrenia, “Osaka and Tokyo, July, 2002.

Grand Rounds: “The New Atypicals: Challenges and Opportunities,” 1) Kyoto University, 2) Sapporo

Medical School, 3) Tokushima Medical School and 4) Okayama International Hospital.

CME Lecture: “Borderline Personality Disorder, Medication and the Family.” Conference, on Borderline

Personality Disorder, Research and Treatment, Stanford University Medical Center, September, 2002.

54

54

Grand Rounds: “The New Atypicals.” Northwest Behavioral Healthcare, Department of Mental Health,

Northfield, Ohio, September, 2002.

CME Lecture: “Novel Antipsychotics: What We’ve Learned; What We Need to Know.” Case Western Reserve

University School of Medicine, Cleveland, September, 2002.

CME Lecture: “New Steps in the Evolution of Antipsychotics: The Role of Partial Agonists,” Sponsored by

Bristol-Myers Squibb and Otsuka Pharmaceutical:

San Diego, June, 2002; San Francisco, September, 2002; New York City, September, 2002;

Seattle, March, 2003; Phoenix, April, 2003; Long Island, May, 2003.

Grand Rounds: “The New Atypicals.” Metropolitan State Hospital, Los Angeles, Sept 2002.

Grand Rounds: “The New Atypicals.” San Joaquin Community Mental Health Center, Fresno, September

2002.

Lecture: “Mental Illness and the Workplace.” Section on Labor Law, Annual Meeting of the State Bar of

California, Monterey, October 2002.

Grand Rounds: “The New Atypicals.” San Francisco Veterans Administration Hospital, San Francisco,

October 2002.

Grand Rounds: “Update on the Atypical Antipsychotics.” Department of Psychiatry, University of California at

San Diego, San Diego, October 2002.

Grand Rounds: “Aripiprazole and the New Antipsychotics.” Mood Disorders Program, UCSF, San Francisco,

November 2002.

CME Lecture: “The New Antipsychotics: Are There Differences?” First West Coast ASCP

Psychopharmacology Symposium, San Francisco, November, 2002.

Lecture: “Aripiprazole Efficacy and Safety.” Continuing Education Meeting, BMS, Laguna Nigel, CA

November 2002.

Grand Rounds: “Second Generation Antipsychotics: New Data and New Dilemmas.” Napa State Hospital,

Napa, CA, December 2002.

At the 2002 Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December

2002:

• Chair, Second Annual Session on “Teaching Neuropsychopharmacology,” and presentation of paper

“The ASCP Model Psychopharmacology Currticulum: New Scope and New Audiences.”

• Poster: “Cocomitant Psychotropic Medication Use in a Two-Year Study Comparing Clozapine and

Olanzapine for the Prevention of Suicidal Behavior.”

• Poster: “A Meta-analysis of the Efficacy of Second-Generation Antipsychotics,” (with John Davis)

National Teleconference: “Improving Outcome in Schizophrenia.” Psychlink, Dallas, TX, January 2003.

Grand Rounds: “Update on Mood Disorders.” Carlisle Hospital, Carlisle, PA, January 2003.

Public Lecture: “The Changing American Family: New Roles, Opportunities and Challenges for Men, Women

and Children.”

Dickinson College, Carlisle, PA, January 2003.

Lecture: “The New Atypicals and Treatment of Psychoses at the 2003 Biannual CME Conference.” University

of Wisconsin School of Medicine and Madison Institute of Medicine, Madison, WI, March 2003.

55

55

Plenary Lectures: Annual Meeting Central California Psychiatric Society, Monterey, CA , March 2003.

• “Combined Treatment of Axis I Disorders”

• “The New Atypicals”

Invited Lecture: “Recent Advances in Treatment of Schizophrenia.” Stanford University School of Medicine

Seventh Psychopharmacology Course, Update in Psychopharmacology Clinical Case Conference,

Stanford, March, 2003.

Poster: “The Efficacy of Atypical Antipscychotics Compared to Typical Antipscychotics: A Meta-Analysis.” (with

N Chen and J Davis). International Congress of Schizophrenia Research, Colorado Springs, CO April,

2003.

Presentation: “Effectiveness of Aripiprazole.” Regional Advisory Council – Bristol Myers-Squibb, Phoenix, AZ,

April, 2003.

Grand Rounds: “New Atypicals: New Medications and New Controversies.”

LSUHSC, Shreveport, LA

Baton Rouge CMHC, Baton Rouge, LA, April 2003

Grand Rounds: “Atypicals: New Drugs – New Controversies.” St. Peter Regional Treatment Center, St. Peter,

MN, May 2003.

Invited Lecture: “Combining Medication with Psychotherapy.”

St. Luke’s Hospital, Dept of Psychiatry, Racine, WI

Rogers Memorial Hospital, Dept of Psychiatry, Milwaukee, MN, May 2003.

At the 2003 Annual Meeting of the American Psychiatric Association, San Francisco, May, 2003.

• Lecture, “Clinical Considerations in the Management of First-Episode and Acute Exacerbation of

Schizophrenia,” as part of the industry-supported symposium, Managing the Spectrum of Psychotic

Disorders.

• Discussion, as part of an Issue Workshop: Psychiatric Perspectives on the Execution Process: A

Continuing Conundrum, with HJ Osofsky, RK Bailey, AM Freedman, AL Halpern, DM Mancuso

• Lecture: “Overview of the Efficacy of 2nd and 1st Generation Antipsychotics,” as part of an APA

symposium , Meta-Analyses of the Efficacy of 2nd vs 1st-Generation Antipsychotics, chaired by ID Glick

and JM Davis.

• Discussion, Efficacy of Atypicals in Acute Care Settings, as part of an industry-supported symposium,

Best Practices in Antipsychotic Use.

Plenary Speaker: “Update on Care and Treatment of Schizophrenia.“Southeast Regional Committee, National

Alliance for the Mentally Ill, Pennsylvania Chapter. Norristown State Hospital, Norristown, PA, June

2003.

Grand Rounds: “Atypicals: New Drugs and New Controversies,” June 2003.

• Milwaukee Veterans Administration

• Milwaukee County Mental Health Clinic

• Winnebago Mental Health Clinic

Colloquium: “Recent Trends in the Development of Novel Antipsychotics.” Atascadero State Hospital, CA, July

2003.

Grand Rounds: “Combining Medication with Psychotherapy to Improve Compliance.” Santa Clara Valley

Mental Health Center, August 2003.

Invited Lecture: “A Meta-analysis of Antipsychotic Medications – Are the Second-generation Agents Better

than the First-generation Agents?” 1) Westchester Medical Center and 2) Rockland State Hospital,

August, 2003.

56

56

Lecture Tour: “First vs Second Generation Antipsychotics: Efficacy and Use of Polypharmacy Strategies.”

Asahiyama, Tottari, Osaka, Fukuoka and Saga, Japan, September, 2003.

Grand Rounds: The New Atypical Antipsychotics, Phoenix, October 2003,

• Good Samaritan Hospital

• Phoenix V.A. Hospital

CME: “Management of Treatment Refractory Schizophrenia,” UC Davis and Sacramento County, September

2003.

Grand Rounds: “Use of Atypicals in Special Populations,” at the Medical College of Georgia and at Augusta

VA Psychiatric Hospital, Augusta, GA, October, 2003.

Grand Rounds: “New Treatments for Psychosis,” at the Mayo Clinic, at the University of Minnesota Medical

School and at Minneapolis VA Medical Center, October, 2003.

Grand Rounds: “New Treatment for Treatment Resistant Schizophrenia,” Kirby Forensic Psychiatric Center,

New York City, November, 2003.

At the Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December 2003:

• Study Group Co-Chair, “New Comparative Studies of Antipsychotics: Evidence from Controlled Trials

versus Clinical Practice” and presentation on Efficacy of Antipsychotics.

• Chair, Third Annual Session on “Teaching of Neuropsychopharmacology.”

• Poster: “Maintenance Therapy with Haloperidol Decanoate or Quetiapine.”

• Poster: “Issues Which May Determine Outcome of Antipsychotic Trials: Populations, Sponsorship,

Design, etc.”

• Poster: “Update on Psychopharmacology Curriculums: Is There Any Relationship of Teaching to Clinical

Practice?”

Grand Rounds: “A Meta-analyses of the Efficacy of Antipsychotics,” Harvard-Longwood Grand Rounds

Services and Caritas St. Elizabeth’s Hospital Series, Boston, January 2004.

Invited Lectures, New Data, Treatments and Controversies about Schizophrenia and Psychosis, India,

February, 2004.

• Goa Psychiatric Society

• Bombay “

• Calcutta “

• Gowati “

• Dehli “

• Kochin-Kerola “

Grand Rounds: “Combining Psychotherapy with Medication: Is It Helpful?” Kern Medical Center, Bakersfield,

CA, April, 2004.

Invited Lecture: “Antipsychotics for Bipolar Disorder: Monotherapy an Adjunct?” Central California Psychiatric

Society, Bakersfield, April, 2004.

At the Annual Meeting of the American Psychiatric Association, New York, May, 2004:

• Issue Workshop participant: “Evidence-based treatment for schizophrenia in a correctional setting.”

• Symposium discussant: “Personality disorders in the workplace.”

• Master Educator Clinical Consultation: “Combining and integrating medication and psychotherapy for

schizophrenia and other Axis I disorders.”

57

57

Grand Rounds: “Practical Management of Psychoses at South Nevada Adult Mental Health Center,” Las

Vegas, May, 2004.

At the Annual Meeting of NCDEU, Phoenix, June 2004

• Poster: “Maintenance Therapy with Haloperidol Decanoate and Quetiapine: A Controlled Random

Assignment Study.”

Lecture: “Families in the Treatment of Personality Disorders and Issues of Compliance.” As part of the

symposium Personality Disorders: Research & Treatment – An Update. Stanford University Medical

Center, June, 2004.

Lecture: “Terrorism, Changing Family Roles and Functions – and Women’s Wellness: Part II.” Women’s

Wellness Rounds, Stanford University School of Medicine, June, 2004.

Grand Rounds: “What Does Psychotherapy Add to Medication Alone for Axis I Disorders.” Dept Psychiatry &

Behavioral Sciences, Stanford Univ School of Medicine, Sept, 2004

Grand Rounds: “Combining Medications and Psychotherapy.” Dept of Psychiatry, University of Iowa School of

Medicine, September, 2004.

Grand Rounds: “Antipsychotic Use in Special Populations.” Dept of Psychiatry, UCSF University Medical

Center, Fresno, CA, October, 2004.

Lecture: “New Treatments for Schizophrenia.” Univ of Oklahoma Health Sciences Center, Oklahoma City,

October, 2004

Grand Rounds: “New Treatments for Psychosis.” Fulton State Hospital, Fulton, MO, Oct, 2004.

Grand Rounds: “New Treatments for Psychosis.” Dept of Psychiatry, University of Missouri, Columbia, MO,

Oct, 2004.

Grand Rounds: “New Treatments for Schizophrenia.” Dept of Psychiatry, Univ of Kansas School of Medicine,

Wichita, KA, October, 2004.

Lecture: “New Treatments of Schizophrenia.” North West Missouri State Hospital, Kansas City, KA, October,

2004.

CME Program: “A Workshop: Interpreting Mental Health Scales and Their Practical Application to Your

Practice.” 2004 US Psychiatric and Mental Health Congress, October, 2004.

• Chair

• Lecture: “Assessment Scales: How Are They Useful?”

At the Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December, 2004:

• Poster: “New Developments in Teaching of Psychopharmacology,” with Sid Zisook.

• Poster: “Second Generation Atypicals vs. First Generation Decanoate,” with Stephen Marder.

• Poster: “Analysis of Industry vs Investigator Initiated Trials,” with John Davis.

• Chair: Fourth Annual ACNP “Teaching of Psychopharmacology” session.

Lecture: “Combination Drug Strategies in Schizophrenia.” As part of the symposium Stanford

Psychopharmacology: Course and Clinical Update. Stanford University Medical Center, March, 2005.

Lecture: “Metabolic Issues of Atypical Antipsychotics.” Dominican Santa Cruz Hospital, March, 2005.

Consultant: “Antipsychotic Drugs.” Smith Barney Citigroup 2005 Healthcare Conference, Washington, D.C.,

March, 2005 (with John Kane, M.D. and Les Citrone, M.D.).

58

58

At the 2005 Annual Meeting of the American Psychiatric Association, Atlanta, GA, May, 2005.

• Debate, Resolved: Seccond Generation Antipsychotics are Uniformly Superior in Safety and Efficacy to

First Generation Antipsychotics.

Moderator: Richard E. D’Alli, MD

Affirmative: Ira D Glick, MD, John M Davis, MD

Negative: Rajiv Tandon, MD, William T Carpenter, Jr., MD

• Chair, Symposium, “Use of Concomitant or Adjunctive Medications in Schizophrenia,”

• Paper presentation, “Efficacy of Concomitant Medications for Stabilized Patients with

Schizophrenia,” (with J Davis).

•Paper presentation, “The Challenge of Teaching Psychopharmacology in the New Millennium:

The Role of Curriculum” (with S Zisook) as part of Symposium “Teaching Psychopharmacology in

the 21st Century.”

• Chair, Symposium, “Inpatient Psychiatry: Crisis and Response.”

• Paper presentation, ”Inpatient Psychiatry at the Turn of the Century” (with G Carter & R Tandon).

ASCP Corner: “Challenges and Opportunities in Teaching Psychopharmacology During Residency Training.”

Zisook S, Glick I, Goldberg DA.” J Clin Psychiatry 66:7, July 2005

Lecture: “Careers in Geriatric Psychopharmacology:” Collaboration with Big Pharma,” at the Eleventh Annual

Summer Research Institute in Geriatric Psychiatry, Stanford University, July 2005

Grand Rounds: “Update on Schizophrenia and Bipolar Disorder.” Sacred Heart Hospital, Spokane, WA,

October, 2005.

Grand Rounds: “Update on Schizophrenia and Bipolar Disorder.” American Lake VA, Tacoma, WA, October,

2005.

CME Lecture: “Overcoming the Issues of Noncompliance in Schizophrenia,” at the 2005 U.S. Psychiatric &

Mental Health Congress, Las Vegas, October, 2005.

Grand Rounds: “New Atypicals.” Shasta Community Mental Health, Redding, October 2005.

At the Annual Meeting of the American College of Neuropsychopharmacology, Hawaii, December, 2005:

• Chair: Fifth Annual “Teaching Neuropsycopharmacology” session: The Neglected Constituencies: Can

Teaching About Psychopharmacology Change Attitudes and Practices?

• Paper: “The Challenge of Teaching at the Academic-Industry Interface” (with Terence Ketter).

Invited CME Lecture: “New Treatments for Schizophrenia,” Psychopharmacology Update for Visiting Clinical

Research Psychiatrists from Spain, Stanford University School of Medicine, January, 2006.

Invited Lecture: “Results From the CATIE Study as a part of the Stanford Psychopharmacology Course and

Clinical Update. Stanford University Medical Center, March 2006.

Grand Rounds: “New Treatments for Schizophrenia.” Bismarck Community Mental Health Center, Bismarck,

North Dakota, April 2006.

Invited Lectures: The CATIE Study: What Does It Mean In the Context of the Field, Japan, May, 2006.

• Tokyo • Akita

• Fukuoa • Nagoya

• Toshugi • Hiroshima

• Saitama

At the Annual Meeting of the American Psychiatric Association, Toronto, May, 2006.

• Poster: “Clinical and Metabolic Impact of Switching Antipsychotic Therapy” (with J Kim and G Reaven)

59

59

Grand Rounds: “The CATIE Study: New Results.” Department of Psychiatry and Behavioral Sciences,

Stanford, CA, June, 2006,

At the Annual NCDEU Meeting, Boca Raton, Florida, June, 2006:

• Poster: “A New Psychopharmacology Curriculum for the Teaching of Psychopharmacology.”

At the Biannual Meeting of the CINP (Collegium Internationale NeuroPsychopharmacologium, Chicago, July

2006

• Presenter: “The CATIE Study in Context,” Debate, (Chair, H. Meltzer)

• CME Update: “Meeting the Challenges of Obtaining Optional Outcomes in Schizophrenia; Improving

Function Over the Long Run,” (with Meltzer H, Altamura C and Lindenmeyer JP)

CME Update: “The CATIE Study.” Fresno Community Mental Health Center, August 2006.

Neuropsychiatry Collaborative Grand Rounds: “New Advances in the Neuroscience and Treatment of

Schizophrenia: The CATIE Study.” Stanford University School of Medicine, September, 2006

At the APA 58th institute on Psychiatric Services, New York, October, 2006:

• Workshop: “Concomitant Medication in Schizophrenia: What We Know, Don’t Know, and Ignore” (with

Miranda Chakos and Jay Patel)

• Poster: “Metabolic Impact and Psychiatric Outcome of Switching Antipsychotic Therapy to

Aripiprazole After Weight Gain” (with J Kim and G Reaven).

Grand Rounds: “Combining Medication with Psychotherapeutic Intervention,” Downstate Medical Center,

SUNY, Brooklyn, October 2006.

Grand Rounds: “The CATIE Study: Clinical Implications,” at the Porterville Developmental Center, and at the

Tulare County Mental Health Clinic, Fresno, CA 2006.

Invited Lectures: 1) The New Model of Acute Inpatient Treatment of Schizophrenia, and 2) Improving the

Efficacy of Outpatient Treatment with Intramuscular Antipsychotic Treatment, China, November, 2006.

• Beijing

• Shanghei

• Sunya

At the Annual Meeting of the ACNP, Hollywood, FL, December 2006

• Posters:

• Onset of response with oral paliperidone extended-release tablets in patients with acute schizophrenia

• Metabolic impact and psychiatric outcome of switching antipsychotic therapy to aripiprazole after

weight gain

• The challenge of teaching psychopharmacology in the new millennium: the role of curricula

• Chair, ACNP Teaching Neuropsychopharmacology Plenary (with S Zisook)

• Co-chair, Issues in Ethics Plenary session (with D Braff)

• Presentation: Working w/Industry Collaboratively and Ethically

Lecture: Schizophrenia: Current Treatment. Rockland Psychiatric Center, White Plains, NY, December 2006.

Lecture: “New Models for Inpatient Psychiatry and Partial Hospitalization Programs.” Outpatient Psychiatric

Services, Fairmont Hospital Campus, San Leandro, CA January, 2007.

Lecture: “CATIE Investigator Education Series.” Los Angeles, Seattle and San Francisco, Winter, 2007

Grand Rounds: “The CATIE Trial in Context.” University of Utah Neuropsychiatric Institute (UNI), Salt Lake

City, UT, February 2007.

60

60

Lecture: “Update on Treatment of Schizophrenia: Data from CATIE & Cutlass Trial.” 11th Annual

Psychopharmacology Course & Clinical Update 2007. Stanford University School of Medicine, Department of

Psychiatry & Behavioral Sciences, Stanford, CA, March, 2007.

Lecturer: “CATIE Investigators’ Educational Series,” Los Angeles, San Francisco, Seattle, March, 2007.

Invited Plenary Lecture: “New Treatment Options for Schizophrenia,” at the Global Meeting Training-the-

Trainees (Paleperidone ER). Johnson & Johnson Pharmaceutical, Barcelona, Spain, May 2007.

At the Annual Meeting of the Society of Biological Psychiatry, San Diego, May 2007

• Presenter and Moderator: Workshop on “Concomitant Medication in Schizophrenia” (with Miranda Chakos)

• Poster: “Determination of onset of response to treatment with paliperidone extended-release in patients with

acute schizophrenia.”

At the Annual Meeting of the American Psychiatric Association, San Diego, May 2007

• Paper: “An Overview of the Field of Sports Psychiatry,” as part of a symposium, “How to Practice Sports

Psychiatry: A Demonstration.”

Grand Rounds: “Understanding and Treating Schizophrenia: Final Results from the CATIE Study.” Stanford

University School of Medicine, Stanford, May, 2007.

Grand Rounds: “The CATIE Study and New Treatments for Schizophrenia,” at the MetroHealth Hospital and at

the Department of Psychiatry, Case Western State University, Cleveland, June 2007

Invited Lecture. “The New Model of Inpatient Psychiatry: Intensive Care and Beyond,” Contra Costa Medical

Center, Martinez, CA, November, 2007.

At the Annual Meeting of the ACNP, Boca Raton, Florida, December, 2007

• Co-chair, ACNP Teaching Neuropsychopharmacology – An Epiphany for Psychopharmacology

Education for Residents and Practitioners: A Demonstration (with Constantine Lyketsos); •

Presentation: “Using a Model Curriculum for the Standard Lecture Format: Having the Content and

Lighting the Fire,” (with Sid Zisook).

• Posters:

• Industry sponsorship and outcome at antipsychotic trials (with John Davis)

• Do concomitant medications improve outcome of antipsychotic monotherapy for stabilized patients

with non-acute schizophrenia? (with John Davis)

• Patterns of response with paliperidone ER and placebo in patients with schizophrenia (with C Bossie,

C Canuso, Y Zhu and L Alphhs)

Grand Rounds: “Proven Efficacy in Schizophrenia: Highlights.” Kaweah Delta Mental Health Hospital, Visalia,

CA, January, 2008

Resident Forum: “Schizophrenia Update,” UCSF Fresno Center, Fresno, CA, January, 2008

Grand Rounds: “Current Treatment of Schizophrenia after CATIE and CUtLASS.” Department of Psychiatry,

New York University School of Medicine, NY, March 2008.

At the Annual Meeting of the American Psychiatric Association, Washington, DC, May 2008.

•Posters:

• “Aripiprzole in the Treatment of Schizoaffective Disorder Patients: A Pooled Analysis from Two

Randomized, Double-blind, Placebo-controlled Trials,” first author.

• “Patterns of Response with Paliperidone ER and Placebo in Patients with Schizophrenia,” first author.

61

61

At the NCDEU Annual Meeting, Phoenix, AZ, May, 2008

Poster: The efficacy of aripiprazole on the five dimensions of schizophrenia derived by factor analysis:

Pooled data from five short-term studies (with Philip Janicak et al)

Workshop: Psychopharmacology Education for Residents, Clinicians, and Industry Personnel: A

Demonstration. Chair

Presentation: Teaching Psychopharmacology: A Complete Curriculum

At the XXVI CINP Congress – 50th Anniversary of the CINP, Munich, Germany, July, 2008

Paper: “What have we learned from the present generation of multi-target agents for schizophrenia? How

does pharmacology link to clinical actions?” (with Davis J and Leucht S)

Grand Rounds: “Combining Medication and Psychopharmacology for Axis I Disorders.” Northshore University

Hospital, Glen Cove, New York, Sept 2008

At the Annual Meeting of the Association of Academic Psychiatry, Santa Fe, Sept, 2008

• Poster: “Going globally with a psychopharmacology curriculum for residents, medical students and

clinicians.” (with Zisook, S)

• Special Session: “Problems & strategies of teaching cutting-edge clinical psychopharmacology for

residents and medical students.”

• Workshop: “A group networking exercise to increase collaborative scholarship in writing.” (with Hilty, D)

At the Annual Meeting of the American College of Neuropsychopharmacology, Scottsdale, AZ, Dec. 2008

• Co-Chair, Teaching Neuropsychopharmacology Session. “Teaching Psychopharmacology: Successes and

Failures in Determining Whether Anyone Learned Anything (or Did the Message Get Across?”) 8th Annual

ACNP Educational Plenary Session:

• Presentation: “Evaluating Med Student and Residency Competency in Psychopharmacology.”

• Study Group: Long-Term, Large-Scale Clinical Trials of Psychiatric Medications and Treatment Strategies

Chair: Ira Glick with D Klein, H Kraemer, T Insel, M Trivedi, J Coyne, J Csernansky

• Poster: “Aripiprazole in Schizophrenia Patients wih Comorbid Obsessive-Compulsive Symptoms.”

• Poster: Exploration of Placebo Response Found in Recently Conducted vs. Earlier Trials of Patients with

Schizophrenia,” with Larry Alphs, Ibrahim Turkoz, Carla Canuso, Cynthia Bossie.”

Grand Rounds: “Barriers to Academic-Industry Education and Research Collaboration.” Department of

Psychiatry, Stanford University School of Medicine, Stanford, CA, Feb 2009

Panel Participant: “Psychiatry and Pharma: Where Do We Draw The Line?” Northern California Psychiatric

Society, 50th Annual Meeting, Monterey, CA, March, 2009, with Stotland N and Reus V.

At the Annual Meeting of the American Psychiatric Association,” San Francisco, May, 2009.

• “A New Model for Acute Psychiatric Hospitalization, in the symposia, Advances in Hospital Psychiatry, with

R Tandon.

• “Family Intervention to Improve Efficacy and Effectiveness of Medication for Schizophrenia,” as part of

symposia on Optimizing Treatment Outcome in Axis I Disorders: Augmentation with Family Interventions.

Grand Rounds: Berkshire Medical Center, Pittsfield, MA, July, 2009

• Staying Current in Psychopharmacology

• Current Treatments of Schizophrenia

Medical Expert Witness: at the Trial Academy, International Association of Defense Counsels, Stanford, July

2009.

New York City, Payne Whitney Clinic of New York Hospital and at the Westchester Division of New York Hospital. New York November, 2012.

62

62

Grand Rounds: Mid-term and Long-Term Efficacy and Effectiveness of Antipsychotic medications for Schizophrenia: A Data-Driven Personalized Clinical Approach, At the Weill Cornell Medical College, New York City, Payne Whitney Clinic of New York Hospital and at the Westchester Division of New York Hospital. New York November, 2012. Grand Rounds: Mid-term and Long-Term Efficacy and Effectiveness of Antipsychotic medications for Schizophrenia: A Data-Driven Personalized Clinical Approach, At the Weill Cornell Medical College, New York City, Payne Whitney Clinic of New York Hospital and at the Westchester Division of New York Hospital. Beth Israel Medical Center, New York, December 2012.

Invited Lecture.

At the Department of Psychiatry, Polyclinic Hospital School of Medicine, University of Milan, October, 2009.

• Long-term Treatment of Schizophrenia

• The Art of Psychopharmacology

Invited Participant

• “The High Prevalence of Poor Medication Adherence in Schizophrenia,” as part of a Forum, Value of Long-

acting Therapies (LATS), supported in part by Janssen, Las Vegas, October, 2009

At the 3rd International Forum on Innovation in Psychiatry, Milan, Italy, November, 2009

• Long-term Antipsychotic Treatment: Modality, Problems and Comparisons

At the 3rd Annual International Brain Conference, Lake Buena Vista, FL, December, 2009

• An Analysis of Recent Research on Schizophrenia: Long-term Safety and Efficacy of Antipsychotics

At the 48th ACNP Annual Meeting, Hollywood, FL, December, 2009

• Poster: “A Model Curriculum for Teaching Medical Students Psychopharmacology”

• Poster: “Family Presence and Support is Correlated with Outcome for Patients with Chronic Schizophrenia

• Chair, Teaching Neuropsychopharmacology, 9th Annual ACNP Educational Plenary Sessison, “The

Impossible Dream:” Keeping Up with Clinical Neuroscience & Psychopharmacology, Circa 2010

• Lecture: “ A Radical Proposal for Staying Current”

Invited Lecture as part of the Parent-Education Series at Marin Academy, San Rafael, CA, Feb, 2010

• “Family Function and the Teen Years: Surviving, Let-alone Thriving.”

Invited Lecture at the 14th Congress of the Italian Society of Psychopathology (SOPSI), Rome, Feb, 2010

• “Evaluation of the Efficacy of Atypical Antipsychotics on Major Psychosis with Long-term Treatment.”

Invited Lecture at the Northern California Psychiatric Society, 2010, Annual Meeting, Monterey, March, 2010

• “Cutting Edge Treatment for Schizophrenia: New Data and New Treatments for the Clinician”

At the 2010 APA Annual Meeting, New Orleans, May, 2010

• Course organizer and lecturer for Psychopharmacology Master Course, Essential Psychopharmacology:

“Staying on the Cutting Edge of Advances in Clinical Psychopharmacology,”

Lecture, “Pharmacotherapy of Schizophrenia: Clinical Implications of New Research”

• ASCP Psychopharmacology Course, Translating the Psychopharmacology Evidence Base into Practice:

A sampler from ASCP,

Lecture, “Combining Medication and Psychotherapeutic Intervention for Axis I disorders”

At the New Clinical Drug Evaluation Unit Meeting (NCDEU) Boca Raton, FL, June 2010,

Panel• Combining Medication with Psychosocial Intervention to Improve Outcome of Axis I Disorders, Co-

Chair.

63

63

Lecture, “Combining Medication with Psychosocial Intervention to Improve Outcome of Schizophrenia,

(with Marder S)”

At the 2010 ASCP Clinical Update, New York, October, 2010

• Lecture: “Update on the Treatment of Schizophrenia”

At the 2010 Meeting of the German Association for Psychiatry and Psychotherapy, Berlin, Germany, November

2010

• Lecture: “An Overview of Sport Psychiatry: A New Frontier in a Changing World”

At the 2010 Meeting of the American College of Neuropsychopharmacology, Miami, December 2010

• Chair, Teaching Psychopharmacology, 10th Annual ACNP Educational Plenary Session: New

Development in Psychopharmacology

• Paper presentation, The American Society of Clinical Psychopharmacology

Curriculums for 1) Residents, 2) Medical Students, and 3) Primary Care Physicians.

• Posters:

• Long-Term Efficacy & Effectiveness of Antipsychotic Medication for Schizophrenia, A Data-

Driven Personalized, Clinical Approach. (with John Davis)

• New Model Curriculums for Teaching Psychopharmacology to Residents, Medical Students,

and Primary Care Prescribers. (with Bruce Lydiard)

Lecture: Psychopharmacologic Treatments for Schizophrenia, 16th Annual Psychopharmacology

Update, Nevada Psychiatric Association, Las Vegas, February 2011.

At the 2011 APA Annual Meeting, Honolulu, May 2011:

• Lecture: Strategies of Treatment for Treatment Resistant Schizophrenia as part of the Masters Course,

entitled “Essential Psychopharmacology”

• Lecture: Sport Psychiatry and Traumatic Brain Injury: New Frontiers in a Challenging World as

part of a Symposium, Traumatic Brain Injury in the Athlete: Psychiatric Implications (with Reardon, D,

Morse, E, Newmark, T)

• Lecture: The Development of Psychopharmacology for Psychiatric Residents as part of Symposium

The Importance of Biological Psychiatry and Clinical Psychopharmacology in Teaching Psychiatric

Residents (with Peselow, E)

• Co-Chair and Lecture 1. Models of Family and Couples Therapy and 2. Evidence Basis for

Family Intervention in Axis I Disorders as part of Symposium Integrating Couples and Family

Treatment into Patient Care.

At the 51st Annual NCDEU Meeting, Boca Raton, FL, June 2011:

• Research Report: “Long-term Efficacy and Effectiveness of Antipsychotic Medication for Schizophrenia,

a Data-driven Personalized, Clinical Approach” (with Davis J. Marder, S et al)

• Poster: New Model Psychopharmacology Curriculum for Residents, Medical Students and Primary Care

Physicians

Invited Lecture. “The New Psychiatry: Past, Present, (& Maybe) The Future of Treatment”, Rhoda Goldman

Institute, San Francisco, July, 2011.

At the 2011 American Physician Institute CME Course, San Diego, October, 2011, lectures:

64

64

Current Update on Treatment of Schizophrenia

New Medications and New Strategies of Treatment for Schizophrenia over the Long-Run

Invited Lecture, New Data and New Strategies of Treatment for Schizophrenia, Psychiatric Grand Rounds, San

Quentin Prison, CA, October 2011

Invited Lecture, New Neuroscience and Genetic Advances as They Affect Psychology and Psychiatry, at the

Department of Psychology, Lehigh University, Bethlehem, PA, November 2011.

Chair: All-day Update on the Current Understanding and Treatment of Schizophrenia, at the 17th Annual

Psychopharmacology Update, Nevada Psychiatric Association, February 2012.

Lecture, Long-Term Management and Treatment of Chronic Schizophrenia

Lecture: Update on the Treatment of Schizophrenia, Fremont Hospital, Fremont, CA, April, 2012.

At the 2012 American Psychiatric Association Annual Meeting, Philadelphia, May 2012:

Lecture: Psychological Impact of Injury in the Athlete, as part of a symposium, “Rebound and Recovery in the Athlete,” with Tom Newmark

Discussant: “Here One Day - A Film About Bipolar Disorder and Suicide”

Lecture: “New Treatment for Schizophrenia”, as part of Masters Course, Essential Psychopharmacology

Co-chair and Symposium Discussant: Improving Quality of Care for Patients with Psychiatric Illness: Combining and Integrating Psychopharmacological, Individual, and Family Therapy

At the 2012 NCDEU Annual Meeting, Phoenix, June, 2012

Special Educational Session, Improving the Teaching-Learning Process in Psychopharmacology: A

Demonstration of New Teaching Formats From the ASCP Psychopharmacology Curriculum

o Lecture: The New Seventh Edition of the ASCP Model Psychopharmacology Curriculum

Posters

o Going Electronic: Moving Data and Discovery to Pharmacology Teachers

o Efficacy and Safety/Tolerability of 2 Approaches for Switching to Iloperidone in Patients With

Schizophrenia, With Weiden P, Alva G, et al.

Grand Rounds, Update on Schizophrenia, John George Pavilion of the Alameda County Medical Center, Fremont, CA, July 2012.

Data Monitoring Committee for VA Cooperative Study 576; VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D), 2012-2014

Grand Rounds, New Data and New Strategies for Cutting-Edge Treatments of Schizophrenia, Department of Psychiatry, Weill Cornell Medical College, Payne Whitney Clinic, New York City and at Westchester Division, White Plains, New York, November, 2012.

Grand Rounds, New Data and New Strategies for Cutting-Edge Treatments of Schizophrenia, Department of Psychiatry, Beth Israel Medical Center, New York, December, 2012. At the 2013 American Psychiatric Association, Annual Meeting, San Francisco, May, 2013

Invited Presidential Symposia: Cutting – Edge Treatment of Schizophrenia over the Life Cycle: New Data and New Strategies, Lecture: Mid-Term and Long-Term Treatments of Schizophrenia

65

65

Discussant of Documentary Film, “Unlisted: A Story of Schizophrenia.” At the 2013 NCDEU Annual Meeting, Hollywood, Florida, May, 2013

Lecture: Efficacy of Clozapine and Reasons for Under-utilization, as part of a workshop, The Under-utilization of Clozapine: Reasons and Solutions (Chair JP. Lindenmayer)

Debate Participant: Hybrid Trial Networks. Leveraging Academic Focus to Assess Unproved Mechanism on Drugs in Psychiatric Disorders, as part of a workshop: Neuroscience vs Serendipity in Psychiatric Drug Development: A Debate

Organizer and Lecturer of Workshop, Impediments/Barriers to Effective Teaching – Learning of Psychopharmacology.

o Lecture: The Seven Sins of Psychopharmacology Teaching (Co-author Salzman, C)

Posters: 1)Improving Psychopharmacology Education and Practice: The Quandary of Getting Data and Information to the Teachers and 2) Web-based Curriculums for Teaching Psychopharmacology

Grand Rounds: Mid-Term and Long-Term Treatments of Schizophrenia. University of California, San Diego, San Diego, CA, June 2013. Grand Rounds: Cutting Edge Treatment of Schizophrenia New Research and New Strategies, Albert Einstein College of Medicine and Montefiore Hospital, Bronx, New York, October 2013. Grand Rounds: Mid-Term and Long-Term Treatments of Schizophrenia, Dept of Psychiatry, University of Massachusetts, Wooster, Mass, February 2014. Invited Lecture: The New Neuroscience – and Psychology, Psychiatry and Medicine. Clarke Forum for Contemporary Issues, Dickinson College, February 2014. Invited Lecture: Long-Term Treatment of Schizophrenia, at the 2014 Annual Meeting of the Northern California Psychiatric Society, Monterey, Ca, March 2014. Invited Lecture: New Neuroscience: Psychology, Psychiatry and Medicine. Department of Psychology, Wesleyan

University, Middletown, CT, May 2014.

Invited Lecture: A Focus on Treatment of Schizophrenia: New Data and New Strategies, at the Dept of Psychiatry,

University of Minnesota, Minneapolis, Minnesota, May, 2014.

Grand Rounds: Advances in Drug Treatment of Schizophrenia, Dept of Psychiatry, Alameda Health System, San

Leandro, Ca, June, 2014

At the 2014 Annual American Society of Clinical Psychopharmacology, Hollywood, Fla, June, 2014 (repeated at

the 2014 Annual Meeting of the Am College of Neuropsychopharmacology, , Phoenix, Az):

Poster: Improving Psychopharmacology Education, with Balon, R and Zisook, S

Poster: Web-based Curriculums for Teaching Psychopharmacology, with the A S C P Curriculum

Committee

.Grand Rounds: New Strategies and New Treatments for Schizophrenia, Dept of Psychiatry, Tufts University

School of Medicine, Boston, September, 2014.

66

66

Grand Rounds: Diagnosis and Treatment in 21st Century Psychiatry, Dominican Hospital, Santa Cruz, Ca, Jan,

2015.

Invited Lecture: Combining Medication with Psychotherapeutic Intervention for Psychiatric Disorders, at the

Northern California Psychiatric Society Continuing Education Meeting, San Francisco, Feb, 2015 and at

the Clinical Psychology Trainees Conference of Alameda Health System, Oakland, Ca,, Feb, 2015 .

Middle East Lecture Tour: Grand Rounds, Update on Current Treatment of Schizophrenia, at Dept of Psychiatry,

Hamad Medical Corp Hospital, Doha, Qatar and at Saif Bin Ghubash Hospital, Dubai, U A E, March, 2015

Grand Rounds: New Strategies and Treatments for Long-term Treatment of Schizophrnia, at the Dept of

Psychiatry, NYU School of Medicine, New York, April, 2015.

At the 2015 American Psychiatric Association, Annual Meeting, Toronto, May, 2015

Lecture “ Can We Treat the Cheat? As part of a symposia, “Cheating, Personality Disorders, and Sport Psychiatry,” with Begel, D.

Grand Rounds : New Treatments and New Strategies for Long-term Treatment of Schizophrenia, Howard

University School of Medicine, Washington D.C., May, 2015

At the Annual Meeting of the American Society of Clinical Psychiatry, Miami, June, 2015:

Workshop: How to Use the Model Psychopharmacology Curriculum in Different Teaching

Settings, with Osser, D

Lecture, The Role of LAIs in the Treatment of Schizophrenia: Outcome Data, with Davis, J.

Ira Glick September 10, 2015